STRUNK DIRK
Universitätsinstitut für experimentelle und klinische Zelltherapie
Zentrum für Querschnitt- und Geweberegeneration Salzburg
Publikationen
|
Forscherprofil
422 Publikationen
2022
Beiträge in Fachzeitschriften
Sexually dimorphic estrogen sensing in skeletal stem cells controls skeletal regeneration.
Andrew, TW; Koepke, LS; Wang, Y; Lopez, M; Steininger, H; Struck, D; Boyko, T; Ambrosi, TH; Tong, X; Sun, Y; Gulati, GS; Murphy, MP; Marecic, O; Telvin, R; Schallmoser, K; Strunk, D; Seita, J; Goodman, SB; Yang, F; Longaker, MT; Yang, GP; Chan, CKF;
Nat Commun. 2022; 13(1): 6491
Originalarbeiten (Zeitschrift)
Paired nicking-mediated COL17A1 reframing for junctional epidermolysis bullosa.
Bischof, J; March, OP; Liemberger, B; Haas, SA; Hainzl, S; Petković, I; Leb-Reichl, V; Illmer, J; Korotchenko, E; Klausegger, A; Hoog, A; Binder, HM; Garcia, M; Duarte, B; Strunk, D; Larcher, F; Reichelt, J; Guttmann-Gruber, C; Wally, V; Hofbauer, JP; Bauer, JW; Cathomen, T; Kocher, T; Koller, U;
Mol Ther. 2022; 30(8):2680-2692
Originalarbeiten (Zeitschrift)
Batch Effects during Human Bone Marrow Stromal Cell Propagation Prevail Donor Variation and Culture Duration: Impact on Genotype, Phenotype and Function.
Brachtl, G; Poupardin, R; Hochmann, S; Raninger, A; Jürchott, K; Streitz, M; Schlickeiser, S; Oeller, M; Wolf, M; Schallmoser, K; Volk, HD; Geissler, S; Strunk, D;
Cells. 2022; 11(6):
Originalarbeiten (Zeitschrift)
Synergy of Human Platelet-Derived Extracellular Vesicles with Secretome Proteins Promotes Regenerative Functions.
Gomes, FG; Andrade, AC; Wolf, M; Hochmann, S; Krisch, L; Maeding, N; Regl, C; Poupardin, R; Ebner-Peking, P; Huber, CG; Meisner-Kober, N; Schallmoser, K; Strunk, D;
Biomedicines. 2022; 10(2):
Originalarbeiten (Zeitschrift)
Autophagy in mesenchymal progenitors protects mice against bone marrow failure after severe intermittent stress.
Landspersky, T; Saçma, M; Rivière, J; Hecker, JS; Hettler, F; Hameister, E; Brandstetter, K; Istvanffy, R; Romero Marquez, S; Ludwig, R; Götz, M; Buck, MC; Wolf, M; Schiemann, M; Ruland, J; Strunk, D; Shimamura, A; Myers, KC; Yamaguchi, TP; Kieslinger, M; Leonhardt, H; Bassermann, F; Götze, KS; Geiger, H; Schreck, C; Oostendorp, RAJ;
Blood. 2022; 139(5): 690-703.
Originalarbeiten (Zeitschrift)
COL17A1 editing via homology-directed repair in junctional epidermolysis bullosa.
Petković, I; Bischof, J; Kocher, T; March, OP; Liemberger, B; Hainzl, S; Strunk, D; Raninger, AM; Binder, HM; Reichelt, J; Guttmann-Gruber, C; Wally, V; Piñón Hofbauer, J; Bauer, JW; Koller, U;
Front Med (Lausanne). 2022; 9: 976604
Originalarbeiten (Zeitschrift)
Extra-hematopoietic immunomodulatory role of the guanine-exchange factor DOCK2.
Scharler, C; Poupardin, R; Ebner-Peking, P; Wolf, M; Schreck, C; Brachtl, G; Cronemberger Andrade, A; Krisch, L; Daheron, L; Schallmoser, K; Jürchott, K; Küchler, J; Stachelscheid, H; Volk, HD; Oostendorp, RAJ; Strunk, D;
Commun Biol. 2022; 5(1): 1246
Originalarbeiten (Zeitschrift)
A Novel C-Type Lectin Receptor-Targeted alpha-Synuclein-Based Parkinson Vaccine Induces Potent Immune Responses and Therapeutic Efficacy in Mice
Schmidhuber, S; Scheiblhofer, S; Weiss, R; Cserepes, M; Tovari, J; Gadermaier, G; Bezard, E; De Giorgi, F; Ichas, F; Strunk, D; Mandler, M
VACCINES-BASEL. 2022; 10(9): 1432
Originalarbeiten (Zeitschrift)
A functional corona around extracellular vesicles enhances angiogenesis, skin regeneration and immunomodulation.
Wolf, M; Poupardin, RW; Ebner-Peking, P; Andrade, AC; Blöchl, C; Obermayer, A; Gomes, FG; Vari, B; Maeding, N; Eminger, E; Binder, HM; Raninger, AM; Hochmann, S; Brachtl, G; Spittler, A; Heuser, T; Ofir, R; Huber, CG; Aberman, Z; Schallmoser, K; Volk, HD; Strunk, D;
J Extracell Vesicles. 2022; 11(4): e12207
Originalarbeiten (Zeitschrift)
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
Efficient homology-directed repair CRISPR/Cas9-based gene editing in junctional epidermolysis bullosa keratinocytes
Petkovic, I; Bischof, J; Liemberger, B; March, OP; Reichelt, J; Binder, H; Strunk, D; Bauer, JW; Kocher, T; Koller, U
EXP DERMATOL. 2022; 31(2): E32-E32.
Abstracts (Zeitschrift)
2021
Beiträge in Fachzeitschriften
Hypoxic Conditions Promote the Angiogenic Potential of Human Induced Pluripotent Stem Cell-Derived Extracellular Vesicles.
Andrade, AC; Wolf, M; Binder, HM; Gomes, FG; Manstein, F; Ebner-Peking, P; Poupardin, R; Zweigerdt, R; Schallmoser, K; Strunk, D;
Int J Mol Sci. 2021; 22(8):
Originalarbeiten (Zeitschrift)
Scalable Enrichment of Immunomodulatory Human Acute Myeloid Leukemia Cell Line-Derived Extracellular Vesicles.
Binder, HM; Maeding, N; Wolf, M; Cronemberger Andrade, A; Vari, B; Krisch, L; Gomes, FG; Blöchl, C; Muigg, K; Poupardin, R; Raninger, AM; Heuser, T; Obermayer, A; Ebner-Peking, P; Pleyer, L; Greil, R; Huber, CG; Schallmoser, K; Strunk, D;
Cells. 2021; 10(12):
Originalarbeiten (Zeitschrift)
Self-assembly of differentiated progenitor cells facilitates spheroid human skin organoid formation and planar skin regeneration
Ebner-Peking, P; Krisch, L; Wolf, M; Hochmann, S; Hoog, A; Vari, B; Muigg, K; Poupardin, R; Scharler, C; Schmidhuber, S; Russe, E; Stachelscheid, H; Schneeberger, A; Schallmoser, K; Strunk, D
THERANOSTICS. 2021; 11(17): 8430-8447.
Originalarbeiten (Zeitschrift)
A non-viral and selection-free COL7A1 HDR approach with improved safety profile for dystrophic epidermolysis bullosa.
Kocher, T; Bischof, J; Haas, SA; March, OP; Liemberger, B; Hainzl, S; Illmer, J; Hoog, A; Muigg, K; Binder, HM; Klausegger, A; Strunk, D; Bauer, JW; Cathomen, T; Koller, U;
Mol Ther Nucleic Acids. 2021; 25:237-250
Originalarbeiten (Zeitschrift)
Improving Human Induced Pluripotent Stem Cell-Derived Megakaryocyte Differentiation and Platelet Production.
Krisch, L; Brachtl, G; Hochmann, S; Andrade, AC; Oeller, M; Ebner-Peking, P; Schallmoser, K; Strunk, D;
Int J Mol Sci. 2021; 22(15):
Originalarbeiten (Zeitschrift)
Heparin and Derivatives for Advanced Cell Therapies.
Laner-Plamberger, S; Oeller, M; Rohde, E; Schallmoser, K; Strunk, D;
Int J Mol Sci. 2021; 22(21):
Übersichtsarbeiten
Leveraging immune memory against measles virus as an antitumor strategy in a preclinical model of aggressive squamous cell carcinoma.
Leb-Reichl, VM; Kienzl, M; Kaufmann, A; Stoecklinger, A; Tockner, B; Kitzmueller, S; Zaborsky, N; Steiner, M; Brachtl, G; Trattner, L; Kreideweiss, P; Reinsch, C; Panzner, S; Greil, R; Strunk, D; Bauer, JW; Gratz, IK; Guttmann-Gruber, C; Hofbauer, JP
J IMMUNOTHER CANCER. 2021; 9(10):
Originalarbeiten (Zeitschrift)
Human Platelet Lysate for Good Manufacturing Practice-Compliant Cell Production.
Oeller, M; Laner-Plamberger, S; Krisch, L; Rohde, E; Strunk, D; Schallmoser, K;
Int J Mol Sci. 2021; 22(10):
Übersichtsarbeiten
Acoustophoresis Enables the Label-Free Separation of Functionally Different Subsets of Cultured Bone Marrow Stromal Cells.
Olm, F; Lim, HC; Schallmoser, K; Strunk, D; Laurell, T; Scheding, S;
Cytometry A. 2021; 99(5):476-487
Originalarbeiten (Zeitschrift)
Adherence to minimal experimental requirements for defining extracellular vesicles and their functions.
Poupardin, R; Wolf, M; Strunk, D;
Adv Drug Deliv Rev. 2021; 176:113872
Übersichtsarbeiten
Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial.
Uccelli, A; Laroni, A; Ali, R; Battaglia, MA; Blinkenberg, M; Brundin, L; Clanet, M; Fernandez, O; Marriot, J; Muraro, P; Nabavi, SM; Oliveri, RS; Radue, E; Tello, CR; Schiavetti, I; Sellner, J; Sorensen, PS; Sormani, MP; Wuerfel, JT; Freedman, MS
LANCET NEUROL. 2021; 20(11): 917-929.
Originalarbeiten (Zeitschrift)
Bone marrow stromal cells from MDS and AML patients show increased adipogenic potential with reduced Delta-like-1 expression.
Weickert, MT; Hecker, JS; Buck, MC; Schreck, C; Rivière, J; Schiemann, M; Schallmoser, K; Bassermann, F; Strunk, D; Oostendorp, RAJ; Götze, KS;
Sci Rep. 2021; 11(1): 5944
Originalarbeiten (Zeitschrift)
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
Double-nicking-based correction of junctional epidermolysis bullosa via COL17A1 reframing
Bischof, J; March, OP; Haas, SA; Liemberger, B; Hainzl, S; Hoog, A; Binder, H; Duarte, B; Strunk, D; Larcher, F; Reichelt, J; Bauer, JW; Cathomen, T; Kocher, T; Koller, U
EXP DERMATOL. .. 2021; 30(3):E44-E44.
Abstracts (Zeitschrift)
COL17A1 editing in junctional epidermolysis bullosa keratinocytes via CRISPR/Cas9 induced homology-directed repair
Petkovic, I; Bischof, J; Liemberger, B; Kocher, T; March, OP; Reichelt, J; Binder, HM; Strunk, D; Bauer, JW; Koller, U
HUM GENE THER. 2021; 32(19-20): A65-A65.
Abstracts (Zeitschrift)
Nichtpublizierte (nicht zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
AML-derived extracellular vesicles convey immunomodulatory potential.
Binder, HM; Maeding, N; Vári, B; Raninger, A; Wolf, M; Heuser, T; Obermayr, A; Brachtl, G; Schallmoser, K; Strunk, D
Paracelsus Virtual Science Get Together 2021 – 2. Virtual Science Summer ; 01.07.-01.10.2021; online. 2021.
„AML-derived extracellular vesicles convey immunomodulatory potential.”
Binder, HM; Maeding, N; Vári, B; Raninger, A; Wolf, M; Heuser, T; Obermayr, A; Brachtl, G; Schallmoser, K; Strunk, D;
4th GSEV 2021 Autumn Meeting; 03.-04.10.2021; Freiburg im Breisgau. 2021.
Extracellular vesicles derived from induced pluripotent stem cells in hypoxic conditions enhance angiogenesis.
Cronemberger, A; Wolf, M; Binder HM; Gueths Gomes F; Manstein, F; Ebner P; Poupardin, R; Zweigerdt, R; Schallmoser, K; Strunk, D
ASEV Young Scientist Meeting 2021; 15.-16.10.2021; Krems. 2021.
Extracellular vesicles derived from induced pluripotent stem cells in hypoxic conditions enhance angiogenesis.
Cronemberger, A; Wolf, M; Binder HM; Gueths Gomes F; Manstein, F; Ebner P; Poupardin, R; Zweigerdt, R; Schallmoser, K; Strunk, D
Paracelsus Virtual Science Get Together 2021 – 2. Virtual Science Summer ; 01.07.-01.10.2021; online. 2021.
Extracellular vesicles derived from induced pluripotent stem cells in hypoxic conditions enhance angiogenesis.
Cronemberger, A; Wolf, M; Binder HM; Gueths Gomes F; Manstein, F; Ebner P; Poupardin, R; Zweigerdt, R; Schallmoser, K; Strunk, D
ISEV Massive EV-Workshop 2021; 28.-29.10.2021; Desenzano. 2021.
Extracellular vesicles derived from induced pluripotent stem cells in hypoxic conditions enhance angiogenesis.
Cronemberger, A; Wolf, M; Binder HM; Gueths Gomes F; Manstein, F; Ebner P; Poupardin, R; Zweigerdt, R; Schallmoser, K; Strunk, D:
4th GSEV 2021 Autumn Meeting; 03.-04.10.2021; Freiburg im Breisgau. 2021.
Human platelet lysate for skin regeneration & immune modulation.
Fausto Gueths Gomes, André Cronemberger Andrade, Martin Wolf, Sarah Hochmann, Linda Krisch, Nicole Maeding, Christof Regl, Patricia Ebner-Peking, Christian Huber, Nicole Meisner-Kober, Katharina Schallmoser, Dirk Strunk
ASEV Young Scientist Meeting 2021; ; 15.-16.10.2021; Krems. 2021.
Human Platelet Lysate for Skin Regeneration & Immune Modulation.
Gueths Gomes, F; Cronemberger A; Wolf, M; Hochmann, S; Krisch, L; Regl, C; Ebner, P; Huber, C; Meisner-Kober, N; Schallmoser, K; Strunk, D
Paracelsus Virtual Science Get Together 2021 – 2. Virtual Science Summer; 01.07.-01.10.2021; online. 2021.
Mesoderm induction improves human induced pluripotent stem cell-derived megakaryocyte differentiation and platelet production.
Krisch, L; Brachtl, G; Hochmann, S; Cronemberger A; Ebner-Peking, P; Öller, M; Schallmoser, K; Strunk, D
Paracelsus Virtual Science Get Together 2021 – 2. Virtual Science Summer ; 01.07.-01.10.2021; online. 2021.
Enhanced angiogenesis and wound healing in vivo induced by extracellular vesicles from therapeutic grade allogeneic human placental stromal cells.
Martin Wolf, Rodolphe Poupardin, Constantin Blöchl, Andre Cronemberger Andrade, Fausto Gueths Gomes, Patrica Peking , Balazs Vari, Essi Eminger; Heide-Marie Binder, Anna M Raninger, Gabi Brachtl, Andreas Spittler, Thomas Heuser, Astrid Obermayer, Christian G Huber, Katharina Schallmoser, Hans-Dieter Volk, Dirk Strunk
10th Annual Meeting ISEV 2021; 18.-21.05.2021; online. 2021.
Essential role of a protein corona around extracellular vesicles in aiding angiogenesis and skin regeneration.
Martin Wolf, Rodolphe W Poupardin, Patricia Ebner-Peking, André Cronemberger Andrade, Constantin Blöchl, Astrid Obermayer, Fausto Gueths Gomes,, Balazs Vari, Essi Eminger, Heide-Marie Binder, Anna M Raninger, Sarah Hochmann, Gabriele Brachtl, Andreas Spittler, Thomas Heuser, Racheli Ofir, Christian G Huber, Zami Aberman, Katharina Schallmoser, Hans-Dieter Volk, Dirk Strunk
GSEV Meeting 2021; 03.-04.10.2021; Freiburg. 2021.
First evidence for a protein corona around extracellular vesicles playing an essential role in aiding angiogenesis and skin regeneration.
Martin Wolf, Rodolphe W Poupardin, Patricia Ebner-Peking, André Cronemberger Andrade, Constantin Blöchl, Astrid Obermayer, Fausto Gueths Gomes,, Balazs Vari, Essi Eminger, Heide-Marie Binder, Anna M Raninger, Sarah Hochmann, Gabriele Brachtl, Andreas Spittler, Thomas Heuser, Racheli Ofir, Christian G Huber, Zami Aberman, Katharina Schallmoser, Hans-Dieter Volk, Dirk Strunk
ASEV Young Scientist Meeting 2021; 15.-16.10.2021; Krems. 2021.
Self-assembly of human iPSC-derived single cells creates skin organoids and regenerates vascularized human skin.
Patricia Ebner, Linda Krisch, Martin Wolf, Anna Hoog, Sarah Hochmann, Balázs Vári, Katharina Muigg, Rodolphe Poupardin, Cornelia Scharler, Sabine Schmidhuber, Elisabeth Russe, Cornelia Hauser-Kronberger, Harald Stachelscheid, Achim Schneeberger, Katharina Schallmoser, Dirk Strunk
Paracelsus Virtual Science Get Together 2021 – 2. Virtual Science Summer; 01.07.-01.10.2021; online. 2021.
Adherence to minimal experimental requirements for defining extracellular vesicles and their functions: A systematic review.
Poupardin Rodolphe, Wolf Martin, Strunk Dirk
ASEV Young Scientist Meeting 2021; 15.-16.10.2021; Krems. 2021.
Cell therapy & Extracellular vesicles
Strunk Dirk
DGTI 2021 online Meeting; 22.09.2021; online. 2021.
Shaping the nanovesicle corona.
Strunk Dirk
ASEV: EV Jour-fixe; 27.05.2021; online. 2021.
2020
Beiträge in Fachzeitschriften
Platelet-derived factors impair placental chorionic gonadotropin beta-subunit synthesis.
Forstner, D; Maninger, S; Nonn, O; Guettler, J; Moser, G; Leitinger, G; Pritz, E; Strunk, D; Schallmoser, K; Marsche, G; Heinemann, A; Huppertz, B; Gauster, M;
J Mol Med (Berl). 2020; 98(2):193-207
Originalarbeiten (Zeitschrift)
Predictable CRISPR/Cas9-Mediated COL7A1 Reframing for Dystrophic Epidermolysis Bullosa.
Kocher, T; March, OP; Bischof, J; Liemberger, B; Hainzl, S; Klausegger, A; Hoog, A; Strunk, D; Bauer, JW; Koller, U;
J Invest Dermatol. 2020; 140(10):1985-1993.e5
Originalarbeiten (Zeitschrift)
A perivascular niche in the bone marrow hosts quiescent and proliferating tumorigenic colorectal cancer cells.
Möhrmann, L; Zowada, MK; Strakerjahn, H; Siegl, C; Kopp-Schneider, A; Krunic, D; Strunk, D; Schneider, M; Kriegsmann, M; Kriegsmann, K; Herbst, F; Ball, CR; Glimm, H; Dieter, SM;
Int J Cancer. 2020; 147(2): 519-531.
Originalarbeiten (Zeitschrift)
Functional assays to assess the therapeutic potential of extracellular vesicles
Nguyen, VVT; Witwer, KW; Verhaar, MC; Strunk, D; van Balkom, BWM
J EXTRACELL VESICLES. 2020; 10(1): e12033
Übersichtsarbeiten
The Expression of CNS-Specific PPARGC1A Transcripts Is Regulated by Hypoxia and a Variable GT Repeat Polymorphism.
Soyal, SM; Bonova, P; Kwik, M; Zara, G; Auer, S; Scharler, C; Strunk, D; Nofziger, C; Paulmichl, M; Patsch, W;
Mol Neurobiol. 2020; 57(2):752-764
Originalarbeiten (Zeitschrift)
Extracellular vesicles from human multipotent stromal cells protect against hearing loss after noise trauma in vivo.
Warnecke, A; Harre, J; Staecker, H; Prenzler, N; Strunk, D; Couillard-Despres, S; Romanelli, P; Hollerweger, J; Lassacher, T; Auer, D; Pachler, K; Wietzorrek, G; Köhl, U; Lenarz, T; Schallmoser, K; Laner-Plamberger, S; Falk, CS; Rohde, E; Gimona, M;
Clin Transl Med. 2020; 10(8): e262
Originalarbeiten (Zeitschrift)
A cancer stem cell-like phenotype is associated with miR-10b expression in aggressive squamous cell carcinomas.
Wimmer, M; Zauner, R; Ablinger, M; Piñón-Hofbauer, J; Guttmann-Gruber, C; Reisenberger, M; Lettner, T; Niklas, N; Proell, J; Sajinovic, M; De Souza, P; Hainzl, S; Kocher, T; Murauer, EM; Bauer, JW; Strunk, D; Reichelt, J; Mellick, AS; Wally, V;
Cell Commun Signal. 2020; 18(1): 61
Originalarbeiten (Zeitschrift)
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
PAIRED SPCAS9 D10A RNPS PRODUCE THE SUBSTRATE FOR EFFICIENT GENE REPAIR VIA HOMOLOGOUS RECOMBINATION IN RDEB PATIENT KERATINONOCYTES
Kocher, T; Cathomen, T; Haas, S; Hoog, A; Strunk, D; Bauer, JW; Koller, U
ACTA DERM-VENEREOL. 2020; 100: 34-35.
Abstracts (Zeitschrift)
TOWARDS PRODUCTION OF IPSC-DERIVED HUMAN PLATELETS FOR REGENERATIVE PURPOSES
L Krisch, M Oeller, C Scharler, P Peking, A Hoog, E Rohde, D Strunk
Vox Sanguinis. 2020; 115 (Suppl. s1): 364-364.-ISBT; 12.-16.12.2020; Virtual Conference.
Abstracts (Zeitschrift)
Acoustophoresis Enables the Label-free Separation of Distinct Subsets from Cultured Bone Marrow Stromal Cells
Olm, F; Lim, HC; Schallmoser, K; Strunk, D; Laurell, T; Scheding, S
BONE MARROW TRANSPL. 2020; 55(SUPPL 1): 683-684.
Abstracts (Zeitschrift)
UPREGULATION OF SOX2 AND ENHANCED PROLIFERATION OF DIFFERENT STROMAL CELLS IN HUMAN PLATELET LYSATE-SUPPLEMENTED CULTURE
S Laner-Plamberger, M Oeller, C Mrazek, A Hartl, A Sonderegger, E Rohde, D Strunk and K Schallmoser
Vox Sanguinis. 2020; 115 (Suppl. s1): 183-183.-ISBT; 12.-16.12.2020; Virtual Conference.
Abstracts (Zeitschrift)
MIRNA-10B MARKS AGGRESSIVE SQUAMOUS CELL CARCINOMAS IN RDEB
Wimmer, M; Zauner, R; Ablinger, M; Pinon-Hofbauer, J; Guttmann-Gruber, C; Reisenberger, M; Lettner, T; Niklas, N; Proell, J; Sajinovic, M; De Souza, P; Hainzl, S; Murauer, EM; Bauer, JW; Strunk, D; Reichelt, J; Mellick, AS; Wally, V
ACTA DERM-VENEREOL. 2020; 100: 35-36.
Abstracts (Zeitschrift)
Nichtpublizierte (nicht zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
Self-assembly of iPSC-derived human vascularized human skin and skin organoids.
Peking, P; Hoog, A; Wolf, M; Scharler, C; Vári, B; Russe, E; Krisch, L; Schallmoser, K; Strunk, D
24. Jahressymposium der IGLD; 05.-07.03.2020; Frankfurt. 2020.
2019
Beiträge in Fachzeitschriften
Multi-Parameter Analysis of Biobanked Human Bone Marrow Stromal Cells Shows Little Influence for Donor Age and Mild Comorbidities on Phenotypic and Functional Properties.
Andrzejewska, A; Catar, R; Schoon, J; Qazi, TH; Sass, FA; Jacobi, D; Blankenstein, A; Reinke, S; Krüger, D; Streitz, M; Schlickeiser, S; Richter, S; Souidi, N; Beez, C; Kamhieh-Milz, J; Krüger, U; Zemojtel, T; Jürchott, K; Strunk, D; Reinke, P; Duda, G; Moll, G; Geissler, S;
Front Immunol. 2019; 10: 2474
Originalarbeiten (Zeitschrift)
Upregulation of mitotic bookmarking factors during enhanced proliferation of human stromal cells in human platelet lysate.
Laner-Plamberger, S; Oeller, M; Mrazek, C; Hartl, A; Sonderegger, A; Rohde, E; Strunk, D; Schallmoser, K;
J Transl Med. 2019; 17(1): 432
Originalarbeiten (Zeitschrift)
Heparin Differentially Impacts Gene Expression of Stromal Cells from Various Tissues.
Laner-Plamberger, S; Oeller, M; Poupardin, R; Krisch, L; Hochmann, S; Kalathur, R; Pachler, K; Kreutzer, C; Erdmann, G; Rohde, E; Strunk, D; Schallmoser, K;
Sci Rep. 2019; 9(1):7258
Originalarbeiten (Zeitschrift)
Extracellular Vesicles Can Deliver Anti-inflammatory and Anti-scarring Activities of Mesenchymal Stromal Cells After Spinal Cord Injury.
Romanelli, P; Bieler, L; Scharler, C; Pachler, K; Kreutzer, C; Zaunmair, P; Jakubecova, D; Mrowetz, H; Benedetti, B; Rivera, FJ; Aigner, L; Rohde, E; Gimona, M; Strunk, D; Couillard-Despres, S;
Front Neurol. 2019; 10: 1225
Originalarbeiten (Zeitschrift)
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
Immune suppression for xeno-cell transplantation strategies in the porcine animal model
Demkes, EJ; Peking, P; van Oostveen, M; de Jager, SCA; Bijsterveld, MPA; Halloin, C; Haase, A; Martin, U; Doevendans, PAF; H?fer, IE; Zweigerdt, R; Strunk, D; Sluijter, JPG
HUM GENE THER. 2019; 30(8): A15-A15.
Abstracts (Zeitschrift)
Upregulation of mitotic bookmarking transcription factors may induce enhanced proliferation of human stromal cells by human platelet lysate
Laner-Plamberger, S; Oeller, M; Mrazek, C; Hartl, A; Rohde, E; Strunk, D; Schallmoser, K
HUM GENE THER. 2019; 30(11): A214-A214.
Abstracts (Zeitschrift)
Highly efficient paired nickase-mediated correction of junctional epidermolysis bullosa via COL17A1 reframing
March, OP; Kocher, T; Liemberger, B; Bischof, J; Hainzl, S; Haas, S; Hochreiter, A; Strunk, D; Cathomen, T; Reichelt, J; Bauer, JW; Koller, U
HUM GENE THER. 2019; 30(11): A173-A173.
Abstracts (Zeitschrift)
Human plasma and platelets from neonatal and adult blood express differential sets of regenerative proteins
Oeller, M; Laner-Plamberger, S; Krisch, L; Rohde, E; Strunk, D; Schallmoser, K
HUM GENE THER. 2019; 30(11): A88-A89.
Abstracts (Zeitschrift)
AML-derived extracellular vesicles transmit immunomodulatory potential
Vari, B; Wolf, M; Raninger, A; Binder, HM; Eminger, E; Strunk, D
HUM GENE THER. 2019; 30(11): A62-A62.
Abstracts (Zeitschrift)
Major player in miRNA processing appear altered in recessive dystrophic epidermolysis bullosa squamous cell carcinoma
Wimmer, M; Zauner, R; Waldmann, A; Bodocian, H; Ablinger, M; Atzmueller, S; Proell, J; Strunk, D; Bauer, JW; Reichelt, J; Wally, V
EUR J HUM GENET. 2019; 27: 109-109.
Abstracts (Zeitschrift)
Proteomic analysis reveals angiogenic and immunomodulatory function for placental stromal cell-derived extracellular vesicles
Wolf, M; Vari, V; Blochl, C; Raninger, AM; Poupardin, R; Eminger, E; Brachtl, G; Oeller, M; Hochreiter, A; Binder, HM; Obermaier, A; Heuser, T; Spittler, A; Seifert, M; Huber, CG; Schallmoser, K; Ofir, R; Aberman, Z; Volk, HD; Strunk, D
HUM GENE THER. 2019; 30(11): A139-A139.
Abstracts (Zeitschrift)
Application of a machine learning approach to identify miRNA fingerprint signatures in recessive dystrophic epidermolysis bullosa
Zauner, R; Wimmer, M; Lettner, T; Atzmuller, S; Proll, J; Guttmann-Gruber, C; Murauer, EM; Reichelt, J; Strunk, D; Bauer, JW; Wally, V
EUR J HUM GENET. 2019; 27: 108-109.
Abstracts (Zeitschrift)
Nichtpublizierte (nicht zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
Batch effect of stromal cell culture conditions prevail donor variation and culture duration effects at the transcriptome and epigenome level.
Brachtl, G; Poupardin, R; Raninger, A; Hoog, A; Schallmoser, K; Jürchott, K; Volk, H-D; Strunk, D;
SCI-TReCS Retreat 2019; 16.-17.09.2019; Wagrain. 2019.
Characterization of extracellular vesicle identity and purity by western blot.
Eminger, E; Vári, B; Raninger, A; Binder, H-M; Poupardin, R; Schallmoser, K; Wolf, M; Strunk, D;
SCI-TReCS Retreat 2019; 16.-17.09.2019; Wagrain. 2019.
Characterization of extracellular vesicle identity and purity by western blot.
Eminger, E; Vári, B; Raninger, A; Binder, HM; Poupardin, R; Schallmoser, K; Wolf, M; Strunk, D;
GSEV & ASEV Autumn Meeting; 28.-29.11.2019; Freising-Weihenstephan. 2019.
How to select the appropriate cell sorting strategy.
Hoog, A; Raninger, AM; Peking, P; Brachtl, G; Strunk D;
SCI-TReCS Retreat 2019; 16.-17.09.2019; Wagrain. 2019.
Optimizing Culture Conditions for the Production of iPSC-derived Megakaryocytes
Krisch, L; Oeller, M; Scharler, C; Peking, P; Strunk, D; Schallmoser, K
SCI-TReCS Retreat 2019; 16.-17.09.2019; Wagrain. 2019.
Enhancement of stem cell differentiation by environmental cues.
Muigg, K; Hoog, A; Scharler, C; Öller, M; Peking, P; Schallmoser, K; Strunk D;
SCI-TReCS Retreat 2019; 16.-17.09.2019; Wagrain. 2019.
Enhancement of human pluripotent stem cell differentiation by environmental cues.
Muigg, K; Hoog, A; Scharler, C; Öller, M; Peking, P; Strunk, D;
Technobeat Symposium Hannover; 02.-04.12.2019; Hannover. 2019.
Label-Free Separation of Mesenchymal Stromal Cell Subpopulations using Acoustophoresis.
Olm, F; Lim, H; Schallmoser, K; Strunk, D; Laurell, T; Scheding, S
34th Congress of the International Society for Advancement of Cytometry; 22.-26.06.2019; Vancouver. 2019.
Development of a human 3D vascularized skin organoid model.
Peking, P; Hochreiter, A; Scharler, C; Vári, B; Wimmer, M; Krisch, L; Wolf, M; Hochmann, S; Schallmoser, K; Strunk, D
ISSCR International Symposium; 20.-22.02.2019; Amsterdam. 2019.
Self-Assembly of human neo-vascularized skin and skin organoids.
Peking, P; Hochreiter, A; Wolf, M; Scharler, C; Vári, B; Krisch, L; Schallmoser, K; Strunk, D
ISSCR Annual Meeting; 26.-29.06.2019; Los Angeles. 2019.
Self-assembly of stem/progenitor cells creates human neo-vascularized skin and skin organoids.
Peking, P; Hoog, A; Wolf, M; Vári, B; Sonderegger, A; Scharler, C; Russe, E; Krisch, L; Schallmoser, K; Strunk, D
ESGCT 27th Annual Congress; 22.-25.10.2019; Barcelona. 2019.
Self-assembly of stem/progenitor cells creates human neo-vascularized skin and skin organoids.
Peking, P; Hoog, A; Wolf, M; Vári, B; Sonderegger, A; Scharler, C; Russe, E; Krisch, L; Schallmoser, K; Strunk, D;
7th Annual GSCN Conference; 23.-25.09.2019; Berlin. 2019.
Self-assembly of stem/progenitor cells creates human neo-vascularized skin and skin organoids.
Peking, P; Hoog, A; Wolf, M; Vári, B; Sonderegger, A; Scharler, C; Russe, E; Krisch, L; Schallmoser, K; Strunk, D;
RESTORE 1st Advanced Therapies Science Meeting; 25.-26.11.2019; Berlin. 2019.
iPSC-based Skin Regeneration.
Peking, P; Hoog, A; Wolf, M; Vári, B; Sonderegger, A; Scharler, C; Russe, E; Krisch, L; Schallmoser, K; Strunk, D;
SCI-TReCS Retreat 2019; 16.-17.09.2019; Wagrain. 2019.
Self-assembly of stem/progenitor cells creates human neo-vascularized skin and skin organoids.
Peking, P; Hoog, A; Wolf, M; Vári, B; Sonderegger, A; Scharler, C; Russe, E; Krisch, L; Schallmoser, K; Strunk D;
7th Annual GSCN Conference; 23.-25.09.2019; Berlin. 2019.
Self-assembly of stem/progenitor cells creates human neo-vascularized skin and skin organoids.
Peking, P; Hoog, A; Wolf, M; Vári, B; Sonderegger, A; Scharler, C; Russe, E; Krisch, L; Schallmoser, K; Strunk D;
SCI-TReCS Retreat 2019; 16.-17.09.2019; Wagrain. 2019.
No identical stromal cells: Transcriptomic meta-Analysis Highlights differences between bone marrow-derived mesenchymal stromal/progenitor cells and other stromal cell sources.
Poupardin, R; Kalathur, RK; Brachtl, G; Jeevan-Raj, BP; Scharler, C; Schallmoser, K; Strunk, D
5th International CCS-Workshop and 15th International CLL-Workshop; 05.-06.04.2019; Fuschl am See. 2019.
A standardized in vitro potency assay allows identifying the immunomodulation potential of independent cell types and extracellular vesicles.
Raninger, A; Ketterl, N; Brachtl, G; Hoog, A; Pachler, K; Oeller, M; Scharler, C; Wolf, M; Vári, B; Binder, H-M; Schallmoser, K; Strunk, D;
SCI-TReCS Retreat 2019; 16.-17.09.2019; Wagrain. 2019.
Therapeutic potential of the vesicular secretome of human stromal cells
Rohde, E; Hollerweger, J; Lassacher, T; Schallmoser, K; Schulze, J; Warnecke, A; Romanelli, P; Couillard-Despres, S; Traweger, A; Strunk, D; Gimona, M
52. Jahrestagung der Deutschen Gesellschaft für Transfusionsmedizin und Immunhämatologie (DGTI); 18.-20.09.2019; Mannheim. 2019.
Stepwise maturation of human iPSC into clonogenic immunosuppressive mesodermal stromal progenitors identified extra-hematopoietic immunomodulatory role of DOCK proteins.
Scharler, C; Ketterl, N; Poupardin, R; Jürchott, K; Wolf, M; Hoog, A; Raninger AM; Brachtl, G; Daheron, L; Schallmoser, K; Stachelscheid, H; Volk, H-D; Strunk, D;
7th Annual GSCN Conference; 23.-25.09.2019; Berlin. 2019.
Stepwise maturation of human iPSC into clonogenic immunosuppressive mesodermal stromal progenitors identified extra-hematopoietic immunomodulatory role of DOCK proteins.
Scharler, C; Ketterl, N; Poupardin, R; Jürchott, K; Wolf, M; Hoog, A; Raninger AM; Brachtl, G; Daheron, L; Schallmoser, K; Stachelscheid, H; Volk, H-D; Strunk, D;
Poster SCI-TReCS Retreat 2019; 16.-17.09.2019; Wagrain. 2019.
Stepwise maturation of human iPSC into clonogenic immunosuppressive mesodermal stromal progenitors identified extra-hematopoietic immunomodulatory role of DOCK proteins.
Scharler, C; Ketterl, N; Poupardin, R; Jürchott, K; Wolf, M; Hoog, A; Raninger AM; Brachtl, G; Daheron, L; Schallmoser, K; Stachelscheid, H; Volk, HD; Strunk, D
RESTORE 1st Advanced Therapies Science Meeting; 25.-26.11.2019; Berlin. 2019.
3D cartilage regeneration capacity of different stromal progenitor cells.
Sonderegger, A; Hochmann, S; Mittermeir, M; Peking, P; Wolf, M; Poupardin P; Strunk D;
SCI TReCS Retreat 2019; 16.-17.09.2019; Wagrain. 2019.
Stem cells in regenerative therapies: mesenchymal stromal cells.
Strunk, D;
7th Annual GSCN Conference; 23.-25.09.2019; Berlin. 2019.
Extracellular vesicles: nano-sized all-rounders.
Strunk, D;
7th Annual GSCN Conference; 23.-25.09.2019; Berlin. 2019.
Extracellular Vesicles Mediating Vascular Regeneration and Immunomodulation.
Strunk, D;
IGLD 2019; 07.-08.03.2019; Frankfurt/Main. 2019.
Novel stem cell- and gene-based regenerative therapies
Strunk, D;
AoP Orphan Science Day; 19.06.2019; Wien. 2019.
Progress and risks in Mesenchymal Stromal Cell therapies.
Strunk, D;
Pre X-Mas Symposium Technobeat; 3.-4.12.2019; Hannover. 2019.
Extracellular vesicles: nano-sized all-rounders.
Strunk, D;
7th Annual GSCN Conference; 23.-25.09.2019; Berlin. 2019.
EVs & Cell Therapy.
Strunk, D;
Extracellular Vesicles: Progress Towards Diagnostics and Therapy; 09.-11.10.2019; Stockholm. 2019.
REGENERATIVE STEM CELL TRANSPLANTATION: Lessons learned from BMT.
Strunk, D;
Guest Lecture; 14.11.2019; Medical University of Graz. 2019.
AML-derived extracellular vesicles convey immunomodulatory potential.
Vári, B; Binder, HM; Raninger, A; Wolf, M; Girgis R; Heuser, T; Mayr, C; Brachtl, G; Schallmoser, K; Strunk, D
ESGCT 27th Annual Congress; 22.-25.10.2019; Barcelona. 2019.
AML-derived extracellular vesicles convey immunomodulatory potential.
Vári, B; Binder, HM; Raninger, A; Wolf, M; Girgis R; Heuser, T; Mayr, C; Brachtl, G; Schallmoser, K; Strunk, D;
7th Annual GSCN Conference; 23.-25.09.2019; Berlin. 2019.
AML-derived extracellular vesicles convey immunomodulatory potential.
Vári, B; Binder, HM; Raninger, A; Wolf, M; Girgis R; Heuser, T; Mayr, C; Brachtl, G; Schallmoser, K; Strunk, D;
SCI-TReCS Retreat 2019; 16.-17.09.2019; Wagrain. 2019.
AML-derived extracellular vesicles convey immunomodulatory potential.
Vári, B; Binder, HM; Raninger, A; Wolf, M; Girgis R; Heuser, T; Mayr, C; Brachtl, G; Schallmoser, K; Strunk, D;
GSEV & ASEV Autumn Meeting; 28.-29.11.2019; Freising-Weihenstephan. 2019.
Instruction of the bone marrow niche by leukemic cells.
Vári, B; Raninger, A; Wolf, M; Brachtl, G; Binder, H-M; Girgis, R; Obermayer, A; Mayr, C; Schallmoser, K; Strunk, D
5th International CCS Workshop and 15th International CLL Workshop; 05.-06.04.2019; Fuschl am See. 2019.
Proteomic analysis reveals angiogenic and immunomodulatory function for placental stromal cell-derived extracellular vesicles.
Wolf, M; Vári, B; Blöchl, C; Raninger, AM; Poupardin, R; Beez, CM; Hoog, A; Brachtl, G; Eminger, E; Oeller, M; Spittler, A; Heuser, T; Obermayer, A; Seifert, M; Huber, CG; Schallmoser, K; Ofir, R; Aberman, Z; Volk, H-D; Strunk D;
7th Annual GSCN Conference; 23.-25.09.2019; Berlin. 2019.
Proteomic analysis reveals angiogenic and immunomodulatory function for placental stromal cell-derived extracellular vesicles.
Wolf, M; Vári, B; Blöchl, C; Raninger, AM; Poupardin, R; Beez, CM; Hoog, A; Brachtl, G; Eminger, E; Oeller, M; Spittler, A; Heuser, T; Obermayer, A; Seifert, M; Huber, CG; Schallmoser, K; Ofir, R; Aberman, Z; Volk, H-D; Strunk D;
SCI-TReCS Retreat 2019; 16.-17.09.2019; Wagrain. 2019.
Biology & Function of Stromal Cell-derived EVs.
Wolf, M; Vári, B; Blöchl, C; Raninger, AM; Poupardin, R; Beez, CM; Hoog, A; Brachtl, G; Eminger, E; Oeller, M; Spittler, A; Heuser, T; Obermayer, A; Seifert, M; Huber, CG; Schallmoser, K; Ofir, R; Aberman, Z; Volk, HD; Strunk, D
SCI-TReCS Retreat 2019; 16.-17.09.2019; Wagrain. 2019.
Proteomic analysis reveals angiogenic and immunomodulatory function for placental stromal cell-derived extracellular vesicles.
Wolf, M; Vári, B; Blöchl, C; Raninger, AM; Poupardin, R; Beez, CM; Hoog, A; Brachtl, G; Eminger, E; Oeller, M; Spittler, A; Heuser, T; Obermayer, A; Seifert, M; Huber, CG; Schallmoser, K; Ofir, R; Aberman, Z; Volk, HD; Strunk D
ESGCT 27th Annual Congress; 22.-25.10.2019; Barcelona. 2019.
Proteomic analysis reveals angiogenic and immunomodulatory function for placental stromal cell-derived extracellular vesicles.
Wolf, M; Vári, B; Blöchl, C; Raninger, AM; Poupardin, R; Beez, CM; Hoog, A; Brachtl, G; Eminger, E; Oeller, M; Spittler, A; Heuser, T; Obermayer, A; Seifert, M; Huber, CG; Schallmoser, K; Ofir, R; Aberman, Z; Volk, HD; Strunk D
RESTORE 1st Advanced Therapies Science Meeting; 25.-26.11.2019; Berlin. 2019.
Proteomic analysis reveals angiogenic and immunomodulatory function for placental stromal cell-derived extracellular vesicles.
Wolf, M; Vári, B; Blöchl, C; Raninger, AM; Poupardin, R; Beez, CM; Hoog, A; Brachtl, G; Eminger, E; Oeller, M; Spittler, A; Heuser, T; Obermayer, A; Seifert, M; Huber, CG; Schallmoser, K; Ofir, R; Aberman, Z; Volk, HD; Strunk D;
GSEV & ASEV Autumn Meeting; 28.-29.11.2019; Freising-Weihenstephan. 2019.
Placental stromal cell-derived extracellular vesicles display immunomodulatory capacity and pro-angiogenic function.
Wolf, M; Vári, B; Raninger, A; Obermayer, A; Poupardin, R; Schallmoser, K; Ofir, R; Strunk, D
5th International CCS Workshop and 15th International CLL Workshop; 05.-06.04.2019; Fuschl am See. 2019.
2018
Beiträge in Fachzeitschriften
Low-dose calcipotriol can elicit wound closure, anti-microbial, and anti-neoplastic effects in epidermolysis bullosa keratinocytes.
Guttmann-Gruber, C; Tockner, B; Scharler, C; Hüttner, C; Common, JE; Tay, ASL; Denil, SLIJ; Klausegger, A; Trost, A; Breitenbach, J; Schnitzhofer, P; Hofbauer, P; Wolkersdorfer, M; Diem, A; Laimer, M; Strunk, D; Bauer, JW; Reichelt, J; Lang, R; Piñón Hofbauer, J;
Sci Rep. 2018; 8(1): 13430
Originalarbeiten (Zeitschrift)
Evaluation of modified Interferon alpha mRNA constructs for the treatment of non-melanoma skin cancer.
Hochmann, S; Mittermeir, M; Santic, R; Koszik, F; Griessner, L; Sonderegger, AS; Hoffmann, T; Russe, E; Scheiblhofer, S; Weiss, R; Mandler, M; Schneeberger, A; Strunk, D;
Sci Rep. 2018; 8(1): 12954
Originalarbeiten (Zeitschrift)
Selection of Tissue Factor-Deficient Cell Transplants as a Novel Strategy for Improving Hemocompatibility of Human Bone Marrow Stromal Cells
Oeller, M; Laner-Plamberger, S; Hochmann, S; Ketterl, N; Feichtner, M; Brachtl, G; Hochreiter, A; Scharler, C; Bieler, L; Romanelli, P; Couillard-Despres, S; Russe, E; Schallmoser, K; Strunk, D
THERANOSTICS. 2018; 8(5): 1421-1434.
Originalarbeiten (Zeitschrift)
International Forum on GMP-grade human platelet lysate for cell propagation.
Strunk, D; Lozano, M; Marks, DC; Loh, YS; Gstraunthaler, G; Schennach, H; Rohde, E; Laner-Plamberger, S; Öller, M; Nystedt, J; Lotfi, R; Rojewski, M; Schrezenmeier, H; Bieback, K; Schäfer, R; Bakchoul, T; Waidmann, M; Jonsdottir-Buch, SM; Montazeri, H; Sigurjonsson, OE; Iudicone, P; Fioravanti, D; Pierelli, L; Introna, M; Capelli, C; Falanga, A; Takanashi, M; López-Villar, O; Burnouf, T; Reems, JA; Pierce, J; Preslar, AM; Schallmoser, K;
Vox Sang. 2018; 113(1):e1-e25
Letter
International Forum on GMP-grade human platelet lysate for cell propagation: summary.
Strunk, D; Lozano, M; Marks, DC; Loh, YS; Gstraunthaler, G; Schennach, H; Rohde, E; Laner-Plamberger, S; Öller, M; Nystedt, J; Lotfi, R; Rojewski, M; Schrezenmeier, H; Bieback, K; Schäfer, R; Bakchoul, T; Waidmann, M; Jonsdottir-Buch, SM; Montazeri, H; Sigurjonsson, OE; Iudicone, P; Fioravanti, D; Pierelli, L; Introna, M; Capelli, C; Falanga, A; Takanashi, M; Lόpez-Villar, O; Burnouf, T; Reems, JA; Pierce, J; Preslar, AM; Schallmoser, K;
Vox Sang. 2018; 113(1):80-87
Übersichtsarbeiten
Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation.
Trento, C; Bernardo, ME; Nagler, A; Kuçi, S; Bornhäuser, M; Köhl, U; Strunk, D; Galleu, A; Sanchez-Guijo, F; Gaipa, G; Introna, M; Bukauskas, A; Le Blanc, K; Apperley, J; Roelofs, H; Van Campenhout, A; Beguin, Y; Kuball, J; Lazzari, L; Avanzini, MA; Fibbe, W; Chabannon, C; Bonini, C; Dazzi, F;
Biol Blood Marrow Transplant. 2018; 24(11):2365-2370
Originalarbeiten (Zeitschrift)
Effects of linagliptin on endothelial function and postprandial lipids in coronary artery disease patients with early diabetes: a randomized, placebo-controlled, double-blind trial.
Tripolt, NJ; Aberer, F; Riedl, R; Url, J; Dimsity, G; Meinitzer, A; Stojakovic, T; Aziz, F; Hödl, R; Brachtl, G; Strunk, D; Brodmann, M; Hafner, F; Sourij, H;
Cardiovasc Diabetol. 2018; 17(1): 71
Originalarbeiten (Zeitschrift)
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
Influence of Heparin on Gene Expression of Stromal Cells Derived from Different Tissues
Laner-Plamberger, S; Oeller, M; Kalathur, R; Poupardin, R; Hochmann, S; Brachtl, G; Pachler, K; Kreutzer, C; Strunk, D; Rohde, E; Schallmoser, K
TRANSFUSION. 2018; 58: 66A-67A.
Abstracts (Zeitschrift)
Plasma Rotational Thrombelastometry for Evaluation of Hemocompatibility of Human Umbilical Cord Derived Stromal Cells
Oeller,M, Laner-Plamberger, S; Brachtl, G; Rohde, E; Strunk, D; Schallmoser, K;
Transfusion. 2018; 58: 68A-69A.-AABB Annual Meeting; 13.-16.10.2018; Boston.
Abstracts (Zeitschrift)
Generation of immunosuppressive iPSC-derived stromal cells for tissue regeneration
Scharler, C; Peking, P; Ketterl, N; Hochreiter, A; Juerchott, K; Brachtl, G; Wimmer, M; Hochmann, S; Wolf, M; Schallmoser, K; Volk, HD; Strunk, D
HUM GENE THER. 2018; 29(12): A56-A56.
Abstracts (Zeitschrift)
Extracellular vesicles of placental expanded stromal cells have immunomodulatory capacity and pro-angiogenic function
Wolf, M; Vari, B; Raninger, A; Obermayer, A; Ofir, R; Strunk, D
HUM GENE THER. 2018; 29(12): A63-A64.
Abstracts (Zeitschrift)
Extracellular vesicles of placental expanded stromal cells have immunomodulatory capacity and pro-angiogenic function
Wolf, M; Vari, B; Raninger, A; Obermayer, A; Ofir, R; Strunk, D
HUM GENE THER. 2018; 29(12): A63-A64.
Abstracts (Zeitschrift)
Nichtpublizierte (nicht zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
Towards better understanding of extracellular vesicle-mediated stroma-leukemia crosstalk in the bone marrow niche.
Girgis, R; Raninger, A; Hochreiter, A; Obermayer, A; Schallmoser, K; Brachtl, G; Wolf, M; Strunk, D
SCI-TReCS Retreat 2018; 13.-14.09.2018; Wagrain. 2018.
Addressing skin with IVT mRNA.
Hochmann, S; Mittermeir, M; Santic, R; Scharler, C; Russe, E; Scheiblhofer, S; Weiss, R; Mandler, M; Schneeberger, A; Strunk, D
SCI-TReCS Retreat 2018; 13.-14.09.2018; Wagrain. 2018.
NO IDENTICAL STROMAL CELLS: HUMAN STROMAL PROGENITORS FROM
NON-SKELETAL SOURCES DISPLAY LIMITED CHONDROGENIC POTENTIAL.
Hochmann, S; Scharler, C; Textor, M; Mittermeir, M; Brachtl, G; Föttinger, P; Hochreiter, A; Schmidt-Bleek, K; Ellinghaus, A; Geissler, S; Duda, G; Strunk, D
SCI-TReCS Retreat 2018; 13.-14.09.2018; Wagrain. 2018.
Development of a human 3D vascularized skin organoid model.
Peking, P; Hochreiter, A; Scharler, C; Wimmer, M; Krisch, L; Wolf, M; Hochmann, S; Schallmoser, K; Strunk, D
6th Annual GSCN Conference; 19.-21.09.2018; Heidelberg. 2018.
Development of a human 3D vascularized skin organoid model.
Peking, P; Hochreiter, A; Scharler, C; Wimmer, M; Krisch, L; Wolf, M; Hochmann, S; Schallmoser, K; Strunk, D
SCI-TReCS Retreat 2018; 13.-14.09.2018; Wagrain. 2018.
Development of an iPSC-mediated strategy for skin regeneration.
Peking, P; Hochreiter, A; Scharler, C; Wimmer, M; Krisch, L; Wolf, M; Hochmann, S; Schallmoser, K; Strunk, D
SCI-TReCS Retreat 2018; 13.-14.09.2018; Wagrain. 2018.
Development of an iPSC-mediated strategy for skin regeneration.
Peking, P; Hochreiter, A; Scharler, C; Wimmer, M; Krisch, L; Wolf, M; Hochmann, S; Schallmoser, K; Strunk, D
2018 ESDR Future Leaders Academy; 03.-05.10.2018; Budapest. 2018.
Development of immunosuppressive iPSC-derived stromal cells for tissue regeneration.
Peking, P; Scharler, C; Ketterl, N; Hochreiter, A; Jürchott, K; Höfler, M; Brachtl, G; Wimmer, M; Wolf, M; Hochmann, S; Schallmoser, K; Volk, H-D; Strunk, D
6th Annual GSCN Conference; 19.-21.09.2018; Heidelberg. 2018.
NO IDENTICAL STROMAL CELLS: TRANSCRIPTOMIC META-ANALYSIS HIGHLIGHTS
DIFFERENCES BETWEEN BONE-MARROW-DERIVED MESENCHYMAL
STROMAL/PROGENITOR CELLS AND OTHER STROMAL CELL SOURCES.
Poupardin, R; Kalathur, RK; Brachtl, G; Jeevan-Raj, BP; Scharler, C; Schallmoser, K; Strunk, D
6th Annual GSCN Conference; 19.-21.09.2018; Heidelberg. 2018.
NO IDENTICAL STROMAL CELLS: TRANSCRIPTOMIC META-ANALYSIS HIGHLIGHTS DIFFERENCES BETWEEN BONE-MARROW-DERIVED MESENCHYMAL STROMAL/PROGENITOR CELLS AND OTHER STROMAL CELL SOURCES.
Poupardin, R; Kalathur, RK; Brachtl, G; Jeevan-Raj, BP; Scharler, C; Schallmoser, K; Strunk, D
SCI-TReCS Retreat 2018; 13.-14.09.2018; Wagrain. 2018.
Generation of immunosuppressive iPSC-derived stromal cells for tissue regeneration.
Scharler, C; Peking, P; Ketterl, N; Hochreiter, A; Jürchott, K; Höfler, M; Brachtl, G; Wimmer, M; Wolf, M; Hochmann, S; Schallmoser, K; Volk, HD; Strunk, D
26th Annual Congress of the ESGCT; 16.-19.10.2018; Lausanne. 2018.
No identical MSC: Which stromal cells can be used for cardiac regeneration
Strunk, D
TECHNOBEAT Satellite Meeting for Regenerative Medicine: From iPSCs to Translation; 06.03.2018; Weizmann Institute of Science, Rehovot, Tel Aviv. 2018.
The role of EVs in vascular regeneration and immunomodulation.
Strunk, D
Annual Meeting on Extracellular Vesicles; 22.-23.11.2018; Krems. 2018.
Stammzelltherapie und regenerative Medizin
Strunk, D
FOKUS:PRAXIS Blut; 29.09.2018; Wien. 2018.
Advanced cell therapies: Remaining preclinical and clinical challenges.
Strunk, D
Anniversary Symposium of the Julius Wolff Institute, Universitätsmedizin Charité Berlin; 14.-15.06.2018; Berlin. 2018.
Do we need engraftment in regenerative stem cell therapy?
Strunk, D
Lecture Series of the Center for Pathobiochemistry and Genetics; 20.11.2018; Wien. 2018.
Placental stromal cell-derived extracellular vesicles display immunomodulatory
capacity and pro-angiogenic function.
Wolf, M; Vári, B; Raninger, A; Obermayer, A; Poupardin, R; Schallmoser, K; Ofir, R; Strunk, D
6th Annual GSCN Conference; 19.-21.09.2018; Heidelberg. 2018.
Placental stromal cell-derived extracellular vesicles display immunomodulatory capacity and pro-angiogenic function.
Wolf, M; Vári, B; Raninger, A; Obermayer, A; Poupardin, R; Schallmoser, K; Ofir, R; Strunk, D
SCI-TReCS Retreat 2018; 13.-14.09.2018; Wagrain. 2018.
Placental stromal cell-derived extracellular vesicles display immunomodulatory capacity and pro-angiogenic function.
Wolf, M; Vári, B; Raninger, A; Obermayer, A; Poupardin, R; Schallmoser, K; Ofir, R; Strunk, D
26th Annual Congress of the ESGCT; 16.-19.10.2018; Lausanne. 2018.
2017
Beiträge in Fachzeitschriften
Synergistic effects of dendritic cell targeting and laser-microporation on enhancing epicutaneous skin vaccination efficacy.
Machado, Y; Duinkerken, S; Hoepflinger, V; Mayr, M; Korotchenko, E; Kurtaj, A; Pablos, I; Steiner, M; Stoecklinger, A; Lübbers, J; Schmid, M; Ritter, U; Scheiblhofer, S; Ablinger, M; Wally, V; Hochmann, S; Raninger, AM; Strunk, D; van Kooyk, Y; Thalhamer, J; Weiss, R;
J Control Release. 2017; 266:87-99
Originalarbeiten (Zeitschrift)
An In Vitro Potency Assay for Monitoring the Immunomodulatory Potential of Stromal Cell-Derived Extracellular Vesicles.
Pachler, K; Ketterl, N; Desgeorges, A; Dunai, ZA; Laner-Plamberger, S; Streif, D; Strunk, D; Rohde, E; Gimona, M;
Int J Mol Sci. 2017; 18(7):
Originalarbeiten (Zeitschrift)
DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma.
Sheffield, NC; Pierron, G; Klughammer, J; Datlinger, P; Schönegger, A; Schuster, M; Hadler, J; Surdez, D; Guillemot, D; Lapouble, E; Freneaux, P; Champigneulle, J; Bouvier, R; Walder, D; Ambros, IM; Hutter, C; Sorz, E; Amaral, AT; de Álava, E; Schallmoser, K; Strunk, D; Rinner, B; Liegl-Atzwanger, B; Huppertz, B; Leithner, A; de Pinieux, G; Terrier, P; Laurence, V; Michon, J; Ladenstein, R; Holter, W; Windhager, R; Dirksen, U; Ambros, PF; Delattre, O; Kovar, H; Bock, C; Tomazou, EM;
Nat Med. 2017; 23(3): 386-395.
Originalarbeiten (Zeitschrift)
Stromal Cells Act as Guardians for Endothelial Progenitors by Reducing Their Immunogenicity After Co-Transplantation.
Souidi, N; Stolk, M; Rudeck, J; Strunk, D; Schallmoser, K; Volk, HD; Seifert, M;
Stem Cells. 2017; 35(5): 1233-1245.
Originalarbeiten (Zeitschrift)
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
Regenerative potential of periosteum-derived stromal cells
Brachtl, G; Hochreiter, A; Hochmann, S; Mittermeir, M;
Raninger, A; Schallmoser, K; Wittig, J; Gaggl, A; Strunk, D
Human Gene Therapy. 2017; 28: A89-A90.-25th Anniversary Congress of the ESGCT; 17.-20.10.2017; Berlin.
Abstracts (Zeitschrift)
Addressing skin with in vitro transcribed mRNA
Hochmann, S; Mittermeir, M; Santic, R; Scharler, C;
Scheiblhofer, S; Russe, E; Weiss, R; Mandler, M;
Schneeberger, A; Strunk, D
Human Gene Therapy. 2017; 28: A85-A85.-25th Anniversary Congress of the ESGCT; 17.-20.10.2017; Berlin.
Abstracts (Zeitschrift)
No identical stromal cells: Human stromal progenitors from
non-skeletal sources display limited chondrogenic potential.
Hochmann, S; Scharler, C; Textor, M; Mittermeir, M;
Brachtl, G; Föttinger, P; Hochreiter, A; Schmidt-Bleek, K;
Ellinghaus, A; Geissler, S; Duda, G; Strunk, D
Human Gene Therapy. 2017; 28: A84-A84.-25th Anniversary Congress of the ESGCT; 17.-20.10.2017; Berlin.
Abstracts (Zeitschrift)
A potency assay for monitoring the immunomodulatory
potential of stromal cell-derived extracellular vesicles.
Ketterl, N; Pachler, K; Desgeorges, A; Dunai, Z; Laner-Plamberger, S; Streif, D; Strunk, D; Rohde, E; Gimona, M
Human Gene Therapy. 2017; 28: A85-A86.-25th Anniversary Congress of the ESGCT; 17.-20.10.2017; Berlin.
Abstracts (Zeitschrift)
Human Platelet Lysate Modifications Affect Mesenchymal Stromal Cell Biology Depending on Cell Origin
Laner-Plamberger, S; Öller, M; Brachtl, G; Strunk, D; Hartl, A; Pachler, K; Feichtner, M; Hauser-Kronberger, C; Wiedemann, H; Rohde, E; Schallmoser, K
Vox Sanguinis. 2017; 112(1):285-286.-27th Regional Congress of the International Society of Blood Transfusion; 17.06.-21.06.2017; Copenhagen.
Abstracts (Zeitschrift)
Heparin Changes the Gene Expression Profile of Mesenchymal Stem/Progenitor Cells
Laner-Plamberger, S; Öller, M; Kalathur, R; Strunk, D; Feichtner, M; Pachler, K; Hauser-Kronberger, C; Schallmoser, K; Rohde, E
Vox Sanguinis. 2017; 112(1):66-66.-27th Regional Congress of the International Society of Blood Transfusion; 17.06.-21.06.2017; Copenhagen.
Abstracts (Zeitschrift)
Heparin affects gene expression of mesenchymal stromal cells in a source-dependent manner
Laner-Plamberger, S; Oller, M; Kalathur, R; Strunk, D; Pachler, K; Hauser-Kronberger, C; Schallmoser, K; Rohde, E
TRANSFUS MED HEMOTH. 2017; 44: 80-81.
Abstracts (Zeitschrift)
Heparin affects Gene Expression of Mesenchymal Stromal Cells in a
Source-dependent Manner
Laner-Plamberger, S; Öller, M; Kalathur, R; Strunk, D; Pachler, K; Hauser-Kronberger, C; Schallmoser, K; Rohde, E
Transfusion Medicine and Hemotherapy. 2017; 44(Suppl.1):p.80--50.Jahrestagung der DGTI; 24.-27.10.2017; Köln.
Abstracts (Zeitschrift)
Hemocompatibility of stromal cells depends on tissue factor expression and is influenced by organ origin and culture conditions
Oeller, M; Laner-Plamberger, S; Feichtner, M; Brachtl, G; Dunai, ZA; Russe, E; Rohde, E; Strunk, D; Schallmoser, K
TRANSFUS MED HEMOTH. 2017; 44: 74-74.
Abstracts (Zeitschrift)
Selection of tissue factor-deficient bone marrow stromal cell
transplants as a novel strategy to improve therapeutic
applicability
Oeller, M; Laner-Plamberger, S; Ketterl, N; Feichtner, M; Raninger, A; Hochreiter, A; Brachtl, G; Dunai, ZA; Russe, E; Schulte, M; Rohde, E; Schallmoser, K; Strunk, D
Human Gene Therapy. 2017; 28: A97-A98.-25th Anniversary Congress of the ESGCT; 17.-20.10.2017; Berlin.
Abstracts (Zeitschrift)
Tissue Factor Expression and Hemocompatibility of Stromal Cells Depend on Organ Origin and Culture Conditions
Öller, M; Laner-Plamberger, S; Feichtner, M; Brachtl, G; Dunai, Z; Russe, E; Rohde, E; Strunk, D; Schallmoser, K
Vox Sanguinis. 2017; 112(1):65-66.-27th Regional Congress of the International Society of Blood Transfusion; 17.06.-21.06.2017; Copenhagen.
Abstracts (Zeitschrift)
Hemocompatibility of stromal cells depends on tissue factor expression and is influenced by organ origin and culture
Öller, M; Laner-Plamberger, S; Feichtner, M; Brachtl, G; Dunai, ZA; Russe, E; Rohde, E; Strunk, D; Schallmoser, K
Transfusion Medicine and Hemotherapy. 2017; 44(Suppl.1):p.74--50.Jahrestagung der DGTI; 24.-27.10.2017; Köln.
Abstracts (Zeitschrift)
Neuroprotective activity of mesenchymal stromal cells and their secreted vesicles in a spinal cord contusion rat model
Romanelli, P; Bieler, L; Scharler, C; Pachler, K; Kreutzer, C; Zaunmair, P; Aigner, L; Rivera, FJ; Rohde, E; Benedetti, B; Gimona, M; Strunk, D; Couillard-Despres, S
TRANSFUS MED HEMOTH. 2017; 44: 76-76.
Abstracts (Zeitschrift)
Stepwise maturation of human iPSC into clonogenic
immunosuppressive mesodermal stromal progenitors
identifies key immunomodulatory pathways.
Scharler, C; Ketterl, N; Jürchott, K; Brachtl, G; Schallmoser, K; Volk, HD; Strunk, D
Human Gene Therapy. 2017; 28: A83-A84.-25th Anniversary Congress of the ESGCT; 17.-20.10.2017; Berlin.
Abstracts (Zeitschrift)
Significantly Reduced CFU-F Frequency and Increased Adipogenic Differentiation of Mesenchymal Stem Cells (Msc) in Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)
Weickert, MT; Garz, AK; Hecker, J; Ziegenhain, C; Grath, S; Strunk, D; Peschel, C; Enard, W; Oostendorp, RAJ; Gotze, KS
ANN HEMATOL. 2017; 96: S52-S52.
Abstracts (Zeitschrift)
Transcriptome profiling in recessive dystrophic epidermolysis bullosa patients
Zauner, R; Wimmer, M; Lettner, T; Gruber, C; Murauer, EM; Reichelt, J; Strunk, D; Bauer, JW; Wally, V
J INVEST DERMATOL. 2017; 137(10): S288-S288.
Abstracts (Zeitschrift)
Nichtpublizierte (nicht zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
Addressing skin with IVT mRNA
Hochmann, S; Mittermeir, M; Santic, R; Scharler, C; Scheiblhofer, S; Russe, E; Weiss, R; Mandler, M; Schneeberger, A; Strunk, D
25th Anniversary Congress of the ESGCT; 17.-20.10.2017; Berlin. 2017.
Human mesenchymal progenitors from non-skeletal adult sources display limited chondrogenic Differentiation.
Hochmann, S; Scharler, C; Textor, M; Mittermeir, M; Brachtl, G; Föttinger, P; Hochreiter, A; Geissler, S; Strunk, D
ISSCR Annual Meeting; 14.-17.06.2017; Boston. 2017.
No Identical Stromal Cells: Human Stromal Progenitors from Non-Skeletal Sources Display Limited Chondrogenic Potential
Hochmann, S; Scharler, C; Textor, M; Mittermeir, M; Brachtl, G; Föttinger, P; Hochreiter, A; Schmidt-Bleek, K; Ellinghaus, A; Geissler, S; Duda, G; Strunk, D
25th Anniversary Congress of the ESGCT; 17.-20.10.2017; Berlin. 2017.
Regenerative potential of periosteum-derived stromal cells.
Hochreiter, A; Brachtl, G; Hochmann, S; Mittermeir, M; Raninger, A; Schallmoser, K; Wittig, J; Gaggl, A; Strunk, D
SCI-TReCS Retreat 2017; 11.-12.09.2017; Seeon. 2017.
Long term reproducibility of an animal serum-free potency assay monitoring immune modulation capacity of human mesenchymal stem/progenitor cells (MSPCs).
Ketterl, N; Scharler, C; Brachtl, G; Raninger, A; Hochreiter, A; Schallmoser, K; Strunk D;
SCI-TReCS Retreat 2017; 11.-12.09.2017; Seeon. 2017.
Selection of tissue factor-deficient bone marrow stromal cell transplants as a novel strategy to improve therapeutic applicability
Öller, M; Laner-Plamberger, S; Ketterl, N; Feichtner, M; Raninger, A; Hochreiter, A; Brachtl, G; Dunai, ZA; Russe, E; Schulte, M; Rohde, E; Schallmoser, K; Strunk D
25th Anniversary Congress of the ESGCT; 17.-20.10.2017; Berlin. 2017.
Stepwise maturation of human iPSC into clonogenic immunosuppressive mesodermal stromal progenitors identifies key immunomodulatory pathways
Scharler, C; Ketterl, N; Jürchott, K; Brachtl, G; Schallmoser, K; Volk, HD; Strunk, D
25th Anniversary Congress of the ESGCT; 17.-20.10.2017; Berlin. 2017.
Heart regeneration by iPSC-derivced organoids.
Scharler, C; Ketterl, N; Jürchott, K; Brachtl, G; Schallmoser, K; Volk, HD; Strunk D
SCI-TReCS Retreat 2017; 11.-12.09.2017; Seeon. 2017.
No Identical MSC: Human Stromal Progenitors from Non-Skeletal Sources Display Limited Chondrogenic Potential - Implications for Clinical Trials.
Strunk, D
PEI-GSCN Workshop; 06.11.2017; Berlin. 2017.
Why We Develop iPSC Therapy Strategies.
Strunk, D
EACTS-PACT Joint Symposium "Regenerative Medicine: Taking the Science to the Patient"; 30.11.-01.12.2017; Wien. 2017.
Stromal Cell Therapy: Past – Presence – Future.
Strunk, D
Jahrestagung 2017 der ÖGBT; 22.-24.05.2017; Seggau. 2017.
2016
Beiträge in Fachzeitschriften
Human platelet lysate: Replacing fetal bovine serum as a gold standard for human cell propagation?
Burnouf, T; Strunk, D; Koh, MB; Schallmoser, K;
Biomaterials. 2016; 76: 371-387.
Übersichtsarbeiten
Cryopreserved or Fresh Mesenchymal Stromal Cells: Only a Matter of Taste or Key to Unleash the Full Clinical Potential of MSC Therapy?
Moll, G; Geißler, S; Catar, R; Ignatowicz, L; Hoogduijn, MJ; Strunk, D; Bieback, K; Ringdén, O;
Adv Exp Med Biol. 2016; 951:77-98
Originalarbeiten (Zeitschrift)
A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells.
Reinisch, A; Thomas, D; Corces, MR; Zhang, X; Gratzinger, D; Hong, WJ; Schallmoser, K; Strunk, D; Majeti, R;
Nat Med. 2016; 22(7): 812-821.
Originalarbeiten (Zeitschrift)
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
Leukotriene receptor inhibition mobilizes human stem cells in vivo
Brachtl, G; Hochreiter, A; Jacobs, VR; Schafer, R; Strunk, D
HUM GENE THER. 2016; 27(11): A56-A56.
Abstracts (Zeitschrift)
GMP-Compliant Production of Pooled Human Platelet Lysate – Setting Standards for Xeno-free Cell Propagation
Feichtner, M; Öller, M; Laner-Plamberger, S; Wiedemann, H; Rohde, E; Strunk, D; Schallmoser, K
Transfusion Medicine and Hemotherapy. 2016; 43(Suppl. 1):73--49. Jahrestagung der Deutschen Gesellschaft für Transfusionsmedizin und Immunhämatologie ; 07.-10.09.2016; Nürnberg.
Abstracts (Zeitschrift)
Calcipotriol enhances cathelicidin expression and improves bacterial defense and wound closure in epidermolysis bullosa
Gruber, C; Hofbauer, P; Tockner, B; Scharler, C; Huttner, C; Trost, A; Strunk, D; Bauer, JW; Reichelt, J; Lang, R
EXP DERMATOL. 2016; 25: 35-36.
Abstracts (Zeitschrift)
Understanding the molecular landscape of human bone marrow-derived mesenchymal stem/progenitor cells through meta-analysis
Kalathur, RK; Brachtl, G; Jeevan-Raj, BP; Scharler, C; Reinisch, A; Schallmoser, K; Strunk, D
HUM GENE THER. 2016; 27(11): A65-A65.
Abstracts (Zeitschrift)
Introducing an animal serum-free potency assay to monitor immune modulation capacity of human mesenchymal stem/progenitor cells (MSPCs)
Ketterl, N; Brachtl, G; Scharler, C; Schallmoser, K; Reinisch, A; Strunk, D
HUM GENE THER. 2016; 27(11): A64-A65.
Abstracts (Zeitschrift)
Influence of heparin on the genomic profile of human mesenchymal stromal/progenitor cells
Laner-Plamberger, S; Oller, M; Kalathur, R; Brachtl, G; Strunk, D; Feichtner, M; Hauser-Kronberger, C; Schallmoser, K; Rohde, E
HUM GENE THER. 2016; 27(11): A61-A61.
Abstracts (Zeitschrift)
Efficient expansion of mesenchymal stem/progenitor cells supported by fibrinogen-depleted pooled human platelet lysate
Oller, M; Laner-Plamberger, S; Feichtner, M; Dunai, ZA; Raninger, A; Gimona, M; Hartl, A; Hauser-Kronberger, C; Russe, E; Bieback, K; Rohde, E; Brachtl, G; Scharler, C; Strunk, D; Schallmoser, K
HUM GENE THER. 2016; 27(11): A63-A64.
Abstracts (Zeitschrift)
Fibrinogen-Depleted Pooled Human Platelet Lysate for Efficient Expansion of Mesenchymal Stromal Cells
Öller, M; Laner-Plamberger, S; Feichtner, M; Dunai, ZA; Raninger, A; Gimona, M; Hartl, A; Hauser-Kronberger, C; Russe, E; Bieback, K; Rohde, E; Brachtl, G; Scharler, C; Strunk, D; Schallmoser, K
Vox Sanguinis. 2016; 111(Suppl. 1):285--34th International Congress of the ISBT ; 03.-08.09.2016; Dubai.
Abstracts (Zeitschrift)
Efficient Expansion of Mesenchymal Stromal Cells by Fibrinogen-Depleted Pooled Human Platelet Lysate
Öller, M; Laner-Plamberger, S; Feichtner, M; Dunai, ZA; Raninger, A; Gimona, M; Hartl, A; Hauser-Kronberger, C; Russe, E; Bieback, K; Rohde, E; Brachtl, G; Scharler, C; Strunk, D; Schallmoser, K
Transfusion Medicine and Hemotherapy. 2016; 43(Suppl.1):71--49. Jahrestagung der Deutschen Gesellschaft für Transfusionsmedizin und Immunhämatologie ; 07.-10.09.2016; Nürnberg.
Abstracts (Zeitschrift)
Stepwise maturation of human iPS cells into clonogenic immunosuppressive mesenchymal stem/progenitor cells
Scharler, C; Ketterl, N; Hofler, M; Brachtl, G; Schallmoser, K; Strunk, D
HUM GENE THER. 2016; 27(11): A64-A64.
Abstracts (Zeitschrift)
DNA methylation mapping and computational modeling in a large Ewing sarcoma cohort identifies principles of tumor heterogeneity and their impact on clinical phenotypes
Sheffield, NC; Tirode, F; Grossetete-Lalami, S; Datlinger, P; Schonegger, A; Hadler, J; Walder, D; Ambros, IM; Amaral, AT; de Alava, E; Schallmoser, K; Strunk, D; Rinner, B; Liegl-Atzwanger, B; Huppertz, B; Leithner, A; Dirksen, U; Ambros, P; Delattre, O; Kovar, H; Bock, C; Tomazou, EM
CANCER RES. 2016; 76:
Abstracts (Zeitschrift)
Calcipotriol treatment enhances wound closure and antimicrobial defense in recessive dystrophic epidermolysis bullosa in vitro while inhibiting proliferation and clonogenicity of RDEB cancer cells.
Tockner, B; Scharler, C; Huttner, C; Zurl, A; Strunk, D; Bauer, JW; Reichelt, J; Lang, R; Gruber, C; Hofbauer, JP
MOL BIOL CELL. 2016; 27:
Abstracts (Zeitschrift)
Nichtpublizierte (nicht zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
Leukotriene receptor inhibition mobilizes human stem cells in vivo.
Brachtl, G; Hochreiter, A; Jacobs, VR; Schäfer, R; Strunk, D
4th Annual Meeting of the German Stem Cell Network (GSCN); 12.-14.09.2016; Hannover. 2016.
Leukotriene receptor inhibition mobilizes human stem cells in vivo.
Brachtl, G; Hochreiter, A; Jacobs, VR; Schäfer, R; Strunk, D
ESGCT and ISSCR Collaborative Congress; 18.-21.10.2016; Florenz. 2016.
Leukotriene receptor inhibition mobilizes human stem cells in vivo.
Brachtl, G; Hochreiter, A; Schäfer, R; Strunk, D
3rd PACT-Symposium: Designer Cells Go Clinic; 23.-24.09.2016; Wien. 2016.
Effect of different cell culture conditions on the growth and clonogenicity of MSPCs.
Brachtl, G; Raninger, A; Hochreiter, A; Schäfer, R; Schallmoser, K; Strunk, D
3rd Research Conference of the Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS); 27.10.2016; Salzburg. 2016.
Effect of different cell culture conditions on the growth and clonogenicity of MSPCs.
Brachtl, G; Raninger, A; Hochreiter, A; Schäfer, R; Schallmoser, K; Strunk, D
PMU Science Day; 24.06.2016; Salzburg. 2016.
Rolle von Mesenchymalen Stammzellen in der Organregeneration & Immunmodulation.
Brachtl, G; Strunk, D
20. Jahressymposium der IGLD; 25.-27.02.2016; Hamburg. 2016.
MSPCs from non-skeletal adult sources have an altered chondrogenic regeneration potency.
Hochmann, S; Scharler, C; Textor, M; Brachtl, G; Föttinger, P; Hochreiter, A; Geissler, S; Strunk, D
3rd Research Conference of the Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS); 27.10.2016; Salzburg. 2016.
Understanding the molecular landscape of human bone marrow-derived mesenchymal stem/progenitor cells through meta-analysis.
Kalathur, RK; Brachtl, G; Jeevan-Raj, BP; Scharler, C; Reinisch, A; Schallmoser, K; Strunk, D
4th Annual Meeting of the German Stem Cell Network (GSCN); 12.-14.09.2016; Hannover. 2016.
Understanding the molecular landscape of human bone marrow-derived mesenchymal stem/progenitor cells through meta-analysis.
Kalathur, RK; Brachtl, G; Jeevan-Raj, BP; Scharler, C; Reinisch, A; Schallmoser, K; Strunk, D
ESGCT and ISSCR Collaborative Congress; 18.-21.10.2016; Florenz. 2016.
Understanding the molecular landscape of human BM-derived MSPCs through meta-analysis.
Kalathur, RK; Brachtl, G; Jeevan-Raj, BP; Scharler, C; Reinisch, A; Schallmoser, K; Strunk, D
3rd Research Conference of the Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS); 27.10.2016; Salzburg. 2016.
Introducing an animal serum-free potency assay to monitor immune modulation capacity of human mesenchymal stem/progenitor cells (MSPCs).
Ketterl, N; Brachtl, G; Scharler, C; Schallmoser, K; Reinisch, A; Strunk, D
PMU Science Day; 24.06.2016; Salzburg. 2016.
Introducing an animal serum-free potency assay to monitor immune modulation capacity of human mesenchymal stem/progenitor cells (MSPCs).
Ketterl, N; Brachtl, G; Scharler, C; Schallmoser, K; Reinisch, A; Strunk, D
ESGCT and ISSCR Collaborative Congress; 18.-21.10.2016; Florenz. 2016.
Stepwise maturation of human iPS cells into immunosuppressive mesenchymal stem/progenitor cells.
Scharler, C; Ketterl, N; Höfler, M; Brachtl, G; Schallmoser, K; Strunk, D
4th Annual Meeting of the German Stem Cell Network (GSCN); 12.-14.09.2016; Hannover. 2016.
Stepwise maturation of human iPS cells into immunosuppressive mesenchymal stem/progenitor cells.
Scharler, C; Ketterl, N; Höfler, M; Brachtl, G; Schallmoser, K; Strunk, D
3rd Research Conference of the Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS); 27.10.2016; Salzburg. 2016.
Stepwise maturation of human iPS cells into immunosuppressive mesenchymal stem/progenitor cells.
Scharler, C; Ketterl, N; Höfler, M; Daheron, L; Brachtl, G; Schallmoser, K; Strunk, D
3rd PACT-Symposium: Designer Cells Go Clinic; 23.-24.09.2016; Wien. 2016.
Stepwise maturation of human iPS cells into immunosuppressive mesenchymal stem/progenitor cells.
Scharler, C; Ketterl, N; Höfler, M; Daheron, L; Brachtl, G; Schallmoser, K; Strunk, D
ESGCT and ISSCR Collaborative Congress; 18.-21.10.2016; Florenz. 2016.
Mesenchymale Stammzelltherapie in der Autoimmunität
Strunk, D
Jahrestagung der Österreichischen Gesellschaft für Rheumatologie & Rehabilitation; 01.-03.12.2016; Wien. 2016.
Which Cells for What Clinical Application?
Strunk, D
PACT Symposium “Designer Cells Go Clinic”; 23.-24.09.2016; Wien. 2016.
Stammzelltherapie – Realität und Ausblick
Strunk, D
OEADF Akademie für Dermatologische Fortbildung 2016; 26.-28.05.2016; Wels. 2016.
Don’t get lost in translation: Which stem cells to use for what application?
Strunk, D
10th Annual UK Mesenchymal Stem Cell Meeting; 05.12.2016; York. 2016.
2015
Beiträge in Fachzeitschriften
Positive contrast of SPIO-labeled cells by off-resonant reconstruction of 3D radial half-echo bSSFP.
Diwoky, C; Liebmann, D; Neumayer, B; Reinisch, A; Knoll, F; Strunk, D; Stollberger, R;
NMR Biomed. 2015; 28(1):79-88
Originalarbeiten (Zeitschrift)
The GPR 55 agonist, L-α-lysophosphatidylinositol, mediates ovarian carcinoma cell-induced angiogenesis.
Hofmann, NA; Yang, J; Trauger, SA; Nakayama, H; Huang, L; Strunk, D; Moses, MA; Klagsbrun, M; Bischoff, J; Graier, WF;
Br J Pharmacol. 2015; 172(16): 4107-4118.
Originalarbeiten (Zeitschrift)
A robust potency assay highlights significant donor variation of human mesenchymal stem/progenitor cell immune modulatory capacity and extended radio-resistance.
Ketterl, N; Brachtl, G; Schuh, C; Bieback, K; Schallmoser, K; Reinisch, A; Strunk, D;
Stem Cell Res Ther. 2015; 6: 236
Originalarbeiten (Zeitschrift)
Elevated levels of interleukin 17A and kynurenine in candidemic patients, compared with levels in noncandidemic patients in the intensive care unit and those in healthy controls.
Krause, R; Zollner-Schwetz, I; Salzer, HJ; Valentin, T; Rabensteiner, J; Prüller, F; Raggam, R; Meinitzer, A; Prattes, J; Rinner, B; Strohmaier, H; Quehenberger, F; Strunk, D; Heidrich, K; Buzina, W; Hoenigl, M;
J Infect Dis. 2015; 211(3):445-451
Originalarbeiten (Zeitschrift)
Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper.
Lener, T; Gimona, M; Aigner, L; Börger, V; Buzas, E; Camussi, G; Chaput, N; Chatterjee, D; Court, FA; Del Portillo, HA; O"Driscoll, L; Fais, S; Falcon-Perez, JM; Felderhoff-Mueser, U; Fraile, L; Gho, YS; Görgens, A; Gupta, RC; Hendrix, A; Hermann, DM; Hill, AF; Hochberg, F; Horn, PA; de Kleijn, D; Kordelas, L; Kramer, BW; Krämer-Albers, EM; Laner-Plamberger, S; Laitinen, S; Leonardi, T; Lorenowicz, MJ; Lim, SK; Lötvall, J; Maguire, CA; Marcilla, A; Nazarenko, I; Ochiya, T; Patel, T; Pedersen, S; Pocsfalvi, G; Pluchino, S; Quesenberry, P; Reischl, IG; Rivera, FJ; Sanzenbacher, R; Schallmoser, K; Slaper-Cortenbach, I; Strunk, D; Tonn, T; Vader, P; van Balkom, BW; Wauben, M; Andaloussi, SE; Théry, C; Rohde, E; Giebel, B;
J Extracell Vesicles. 2015; 4: 30087
Originalarbeiten (Zeitschrift)
Epigenetic and in vivo comparison of diverse MSC sources reveals an endochondral signature for human hematopoietic niche formation.
Reinisch, A; Etchart, N; Thomas, D; Hofmann, NA; Fruehwirth, M; Sinha, S; Chan, CK; Senarath-Yapa, K; Seo, EY; Wearda, T; Hartwig, UF; Beham-Schmid, C; Trajanoski, S; Lin, Q; Wagner, W; Dullin, C; Alves, F; Andreeff, M; Weissman, IL; Longaker, MT; Schallmoser, K; Majeti, R; Strunk, D;
Blood. 2015; 125(2): 249-260.
Originalarbeiten (Zeitschrift)
Massive fistulization into the left ventricle of a transplanted heart.
Wallner, M; Zweiker, R; Maier, R; Strunk, D; von Lewinski, D;
Herz. 2015; 40(Supplement 1): 56-58.
Fallberichte
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
Mesenchymal Stem Cells Differentiate into Osteoblasts in the Presence of AML Cells through Up-regulation of RUNX2 and Induce Chemo-resistance
Battula, VL; Le, PM; Sun, J; Mc Queen, T; Somanchi, A; Wang, RY; Strunk, D; Shpall, EJ; Ruvolo, P; Kantarjian, H; Konopleva, M; Andreeff, M
CL LYMPH MYELOM LEUK. 2015; 15: S185-S186.
Abstracts (Zeitschrift)
Allogeneic Stem Cell Transplantation In Patients With Acute Myeloid Leukemia: a report from the Austrian Stem Cell Transplantation Registry (ASCTR)
Bohm, A; Rabitsch, W; Greinix, HT; Kalhs, P; Mitterbauer, M; Schulenburg, A; Wohrer, S; Worel, N; Strunk, D; Linkesch, W; Urban, C; Schwinger, W; Peters, C; Gastl, G; Nachbaur, D; Kircher, B; Clausen, J; Auberger, J; Krieger, O; Kasparu, H; Hauser, H; Machherndl-Spandl, S; Weltermann, A; Lindner, B
CL LYMPH MYELOM LEUK. 2015; 15: S183-S183.
Abstracts (Zeitschrift)
Modifications of human platelet lysate for efficient expansion of mesenchymal stromal cells without fibrinogen.
Öller, M: Feichtner, M; Dunai, ZA; Raninger, A; Laner-Plamberger, S; Lener, T; Streif, D; Gimona, M; Hartl, A; Bieback, K; Wiedemann, H; Rohde, E; Strunk, D; Schallmoser, K
Transfus Med Hemother 2015;42(suppl1):p.63. 2015; -48.Jahrestagung der DGTI (Deutsche Gesellschaft für Transfusionsmedizin und Immunhämatologie e.V.); 15. -18. 09.2015; Basel.
Abstracts (Zeitschrift)
Nichtpublizierte (nicht zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
Does Montelukast mobilize human stem/progenitor cells in vivo?.
Brachtl, G; Hochreiter, A; Strunk, D
2nd Research Conference of the Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS); 05.11.2015; Salzburg. 2015.
Cellular MRI through off-resonant reconstructions.
Diwoky, C; Liebmann, D; Reinisch, A; Strunk, D; Ropele, S; Stollberger, R
BioNanoMed2015, 6th International Congress Nanotechnology in Medicine & Biology; 08.-10.04.2015; Graz. 2015.
Identification of human bone marrow specific mesenchymal stem/progenitor cell (MSPC) gene expression signature through meta-analysis.
Kalathur, RK; Reinisch, A; Strunk, D
3rd International Annual Conference of the German Stem Cell Network (GSCN); 09.-11.09.2015; Frankfurt. 2015.
Comparing gene expression signatures of human mesenchymal stem/progenitor cells (MSPCs) from different organs using bioinformatic tools.
Kalathur, RK; Reinisch, A; Strunk D
World Conference on Regenerative Medicine 2015; 21.-23.10.2015; Leipzig. 2015.
Identification of human bone marrow specific mesenchymal stem/progenitor cell (MSPC) gene expression signature through meta-analysis.
Kalathur, RK; Reinisch, A; Strunk D
2nd Research Conference of the Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS); 05.11.2015; Salzburg. 2015.
Introducing an animal serum-free potency assay to monitor immune modulation capacity of human mesenchymal stem/progenitor cells (MSPCs).
Ketterl, N; Brachtl, G; Schuh, C; Schallmoser, K; Strunk, D
3rd International Annual Conference of the German Stem Cell Network (GSCN); 09.-11.09.2015; Frankfurt. 2015.
Introducing an animal serum-free potency assay to monitor immune modulation capacity of human mesenchymal stem/progenitor cells (MSPCs).
Ketterl, N; Brachtl, G; Schuh, C; Schallmoser, K; Strunk, D
World Conference on Regenerative Medicine 2015; 21.-23.10.2015; Leipzig. 2015.
Introducing an animal serum-free potency assay to monitor immune modulation capacity of human mesenchymal stem/progenitor cells (MSPCs).
Ketterl, N; Brachtl, G; Schuh, C; Schallmoser, K; Strunk, D
2nd Research Conference of the Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS); 05.11.2015; Salzburg. 2015.
Efficient animal serum-free propagation of mesenchymal stem cells by using fibrinogen-depleted modifications of human platelet lysate.
Öller, M; Feichtner, M; Dunai, ZA; Raninger, A; Laner-Plamberger, S; Lener, T; Gimona, M; Hartl, A; Bieback, K; Rohde, E; Strunk, D; Schallmoser, K
World Conference on Regenerative Medicine 2015; 21.-23.10.2015; Leipzig. 2015.
A novel humanized bone marrow niche xenotransplantation model allows superior engraftment of human normal and malignant hematopoietic cells and reveals myelofibrosis-initiating cells in the CD34+/CD38+/CD90+ compartment.
Reinisch, A; Strunk, D; Majeti, R
Keystone Symposium 2015 on Haematopoiesis; 22.-27.02.2015; Keystone, Colorado. 2015.
Optimizing conditions to differentiate human iPS cells into functional mesenchymal stem/progenitor cells.
Schuh, C; Ketterl, N; Höfler, M; Brachtl, G; Schallmoser, K; Strunk, D
3rd International Annual Conference of the German Stem Cell Network (GSCN); 09.-11.09.2015; Frankfurt. 2015.
Optimizing conditions to differentiate human iPS cells into functional mesenchymal stem/progenitor cells.
Schuh, C; Ketterl, N; Höfler, M; Brachtl, G; Schallmoser, K; Strunk D.
World Conference on Regenerative Medicine 2015; 21.-23.10.2015; Leipzig. 2015.
Attenuation of alloimmunity to human Endothelial Colony Forming Cells (ECFC) by interaction with Mesenchymal Stem/Progenitor Cells (MSPC) from umbilical cord.
Souidi, N; Rudeck, J; Stolk, M; Schmitt-Knosalla, I; Schuh, C; Schallmoser, K; Strunk, D; Volk, H-D; Seifert, M
3rd International Annual Conference of the German Stem Cell Network (GSCN); 09.-11.09.2015; Frankfurt. 2015.
Stem Cells in Regenerative Therapies - Overview
Strunk, D
3rd International Annual Conference of the German Stem Cell Network (GSCN); 03.-05.09.2015; Frankfurt. 2015.
Monitorisierung der immunmodulatorischen Kapazität von MSC in klinischen Studien.
Strunk, D
Hyperflow 2015, Meeting der Österreichischen Gesellschaft für Zytometrie; 17.-18.09.2015; Wien. 2015.
Advanced models in human stem cell transplantation
Strunk, D
Humunity Annual Meeting 2015; 21.-22.09.2015; Salzburg. 2015.
Epigenetic and in vivo comparison of diverse MSC sources reveals an endochondral signature for human hematopoietic niche formation.
Strunk, D; Schallmoser, K; Reinisch, A; Majeti, R
Keystone Symposium 2015 on Haematopoiesis; 22.-27.02.2015; Keystone, Colorado. 2015.
2014
Beiträge in Fachzeitschriften
TRPV1 mediates cellular uptake of anandamide and thus promotes endothelial cell proliferation and network-formation.
Hofmann, NA; Barth, S; Waldeck-Weiermair, M; Klec, C; Strunk, D; Malli, R; Graier, WF;
Biol Open. 2014; 3(12):1164-1172
Originalarbeiten (Zeitschrift)
Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-κB mediates chemoresistance.
Jacamo, R; Chen, Y; Wang, Z; Ma, W; Zhang, M; Spaeth, EL; Wang, Y; Battula, VL; Mak, PY; Schallmoser, K; Ruvolo, P; Schober, WD; Shpall, EJ; Nguyen, MH; Strunk, D; Bueso-Ramos, CE; Konoplev, S; Davis, RE; Konopleva, M; Andreeff, M;
Blood. 2014; 123(17): 2691-2702.
Originalarbeiten (Zeitschrift)
Mesenchymal stromal cells from the human placenta promote neovascularization in a mouse model in vivo.
Kinzer, M; Hingerl, K; Konig, J; Reinisch, A; Strunk, D; Huppertz, B; Lang, I
PLACENTA. 2014; 35(7): 517-519.
Originalarbeiten (Zeitschrift)
Effects of directly autotransplanted tibial bone marrow aspirates on bone regeneration and osseointegration of dental implants.
Payer, M; Lohberger, B; Strunk, D; Reich, KM; Acham, S; Jakse, N;
Clin Oral Implants Res. 2014; 25(4): 468-474.
Originalarbeiten (Zeitschrift)
Impact of autogenous concentrated bone marrow aspirate on bone regeneration after sinus floor augmentation with a bovine bone substitute--a split-mouth pilot study.
Wildburger, A; Payer, M; Jakse, N; Strunk, D; Etchard-Liechtenstein, N; Sauerbier, S
Clin Oral Implants Res. 2014; 25(10):1175-1181
Originalarbeiten (Zeitschrift)
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
Acute Myeloid Leukemia Cells Acquire Chemo-Resistance By Inducing Osteoblast Differentiation in Mesenchymal Stem Cells through up-Regulation of RUNX2
Battula, VL; Le, PM; Sun, J; McQueen, T; Somanchi, A; Wang, RY; Strunk, D; Shpall, EJ; Ruvolo, PP; Kantarjian, HM; Konopleva, M; Andreeff, M
BLOOD. 2014; 124(21):
Abstracts (Zeitschrift)
Nichtpublizierte (nicht zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
Acute myeloid leukemia cells acquire chemo-resistance by inducing osteoblast differentiation in mesenchymal stem cells through up-regulation of RUNX2.
Battula, VL; Le, PM; Sun, J; McQueen, T; Somanchi, A; Wang, R-W; Strunk, D; Shpall, EJ; Ruvolo, PP; Kantarjian, HM; Konopleva; Andreeff, M
56th AHS Annual Meeting and Exposition; 06.-09.12.2014; San Francisco. 2014.
U-derived stem/progenitor cells: A noninvasice cell source for regenerative purposes.
Brachtl, G; Schuh, C; Ketterl, N; Höfler, M; Strunk, D
1st Research Conference of the Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS); 13.11.2014; Salzburg. 2014.
U-derived stem/progenitor cells: A noninvasice cell source for regenerative purposes.
Brachtl, G; Schuh, C; Ketterl, N; Höfler, M; Strunk, D
2nd International Annual Conference of the German Stem Cell Network (GSCN); 03.-05.11.2014; Heidelberg. 2014.
Optimizing conditions to differentiate human induced pluripotent stem cells into mesenchymal stem/progenitor cells.
Höfler, M; Schuh, C; Ketterl, N; Brachtl, G; Strunk, D
International Annual Conference of the German Stem Cell Network (GSCN); 03.-05.11.2014; Heidelberg. 2014.
Expression of nucleotide oligomerization domain like receptors in human mesencyhmal stem cells.
Jetzinger, A; Ackaert, C; Duschl, A; Strunk, D; Horejs-Hoeck, J
6th ÖGMBT Annual Meeting; 15.-18.09.2014; Wien. 2014.
Analyzing the immune modulation potential of human mesenchymal stem/progenitor cells.
Ketterl, N; Brachtl, G; Schuh, C; Schallmoser, K; Strunk, D
1st Research Conference of the Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS); 13.11.2014; Salzburg. 2014. ; 13.11.2014; Salzburg. 2014.
Predicting and optimizing the immune modulation potential of human mesenchymal stem/progenitor cells.
Ketterl, N; Brachtl, G, Schuh, C; Schallmoser, K; Strunk, D
2nd International Annual Conference of the German Stem Cell Network (GSCN); 03.-05.11.2014; Heidelberg. 2014.
Optimizing conditions to differentiate human iPS cells into functional mesenchymal stem/progenitor cells.
Schuh, C; Höfler, M; Ketterl, N; Brachtl, G; Strunk, D
1st Research Conference of the Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS); 13.11.2014; Salzburg. 2014.
First do no harm: Translation of regenerative stem cell therapies.
Strunk, D
109th Annual Meeting of the Anatomische Gesellschaft; 25.09.2014; Salzburg. 2014.
Mesenchymal stem/progenitor cell function: Beyond regeneration.
Strunk, D
Foundation Symposium of the platform for advanced cellular therapies (PACT); 04.04.2014; Wien. 2014.
2013
Beiträge in Fachzeitschriften
Connective tissue growth factor regulates adipocyte differentiation of mesenchymal stromal cells and facilitates leukemia bone marrow engraftment.
Battula, VL; Chen, Y; Cabreira, MD; Ruvolo, V; Wang, ZQ; Ma, WC; Konoplev, S; Shpall, E; Lyons, K; Strunk, D; Bueso-Ramos, C; Davis, RE; Konopleva, M; Andreeff, M
Blood. 2013; 122(3):357-366
Originalarbeiten (Zeitschrift)
Chemokine receptors in gastric MALT lymphoma: loss of CXCR4 and upregulation of CXCR7 is associated with progression to diffuse large B-cell lymphoma.
Deutsch, AJA; Steinbauer, E; Hofmann, NA; Strunk, D; Gerlza, T; Beham-Schmid, C; Schaider, H; Neumeister, P
MODERN PATHOL. 2013; 26(2): 182-194.
Originalarbeiten (Zeitschrift)
Donor selection and release criteria of cellular therapy products.
Eichler, H; Schrezenmeier, H; Schallmoser, K; Strunk, D; Nystedt, J; Kaartinen, T; Korhonen, M; Fleury-Cappellesso, S; Sensebé, L; Bönig, H; Rebulla, P; Giordano, R; Lecchi, L; Takanashi, M; Watt, SM; Austin, EB; Guttridge, M; McLaughlin, LS; Panzer, S; Reesink, HW;
Vox Sang. 2013; 104(1): 67-91.
Originalarbeiten (Zeitschrift)
Tri-lineage potential of intraoral tissue-derived mesenchymal stromal cells.
Lohberger, B; Payer, M; Rinner, B; Kaltenegger, H; Wolf, E; Schallmoser, K; Strunk, D; Rohde, E; Berghold, A; Pekovits, K; Wildburger, A; Leithner, A; Windhager, R; Jakse, N;
J Craniomaxillofac Surg. 2013; 41(2):110-118
Originalarbeiten (Zeitschrift)
Identification of an Effective Early Signaling Signature during Neo-Vasculogenesis In Vivo by Ex Vivo Proteomic Profiling
Rohban, R; Reinisch, A; Etchart, N; Schallmoser, K; Hofmann, NA; Szoke, K; Brinchmann, JE; Rad, EB; Rohde, E; Strunk, D
PLOS ONE. 2013; 8(6): e66909
Originalarbeiten (Zeitschrift)
Generation of a pool of human platelet lysate and efficient use in cell culture.
Schallmoser, K; Strunk, D;
Methods Mol Biol. 2013; 946:349-362
Originalarbeiten (Zeitschrift)
A clinically-feasible protocol for using human platelet lysate and mesenchymal stem cells in regenerative therapies.
Warnke, PH; Humpe, A; Strunk, D; Stephens, S; Warnke, F; Wiltfang, J; Schallmoser, K; Alamein, M; Bourke, R; Heiner, P; Liu, Q;
J Craniomaxillofac Surg. 2013; 41(2):153-161
Originalarbeiten (Zeitschrift)
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
Allogeneic stem cell transplantation in patients with acute myeloid leukaemia: a report from the Austrian Stem Cell Transplantation Registry (ASCTR)
Boehm, A; Rabitsch, W; Greinix, HT; Kalhs, P; Mitterbauer, M; Schulenburg, A; Woehrer, S; Worel, N; Strunk, D; Linkesch, W; Urban, C; Schwinger, W; Peters, C; Gastl, G; Nachbaur, D; Kircher, B; Clausen, J; Auberger, J; Krieger, O; Kasparu, H; Hauser, H; Machherndl-Spandl, S; Weltermann, A; Lindner, B
BONE MARROW TRANSPL. 2013; 48: S393-S393.
Abstracts (Zeitschrift)
Nichtpublizierte (nicht zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
Mesenchymale und Endotheliale Stammzellen in der Regenerativen Medizin.
Strunk, D
Stammzelltag der BioCity Leipzig; 07.06.2013; Leipzig. 2013.
Zelltherapie im Rahmen der regenerativen Medizin
Strunk, D
Gewebebank–Symposium der Medizinischen Universität Wien; 20.06.2013; Wien. 2013.
2012
Beiträge in Fachzeitschriften
Third-party mesenchymal stromal cell infusion is associated with a decrease in thrombotic microangiopathy symptoms observed post-hematopoietic stem cell transplantation.
Ansari, M; Strunk, D; Schallmoser, K; Delcò, C; Rougemont, AL; Moll, S; Villard, J; Gumy-Pause, F; Chalandon, Y; Parvex, P; Passweg, J; Ozsahin, H; Kindler, V;
Pediatr Transplant. 2012; 16(2):131-136
Originalarbeiten (Zeitschrift)
Human extramedullary bone marrow in mice: a novel in vivo model of genetically controlled hematopoietic microenvironment.
Chen, Y; Jacamo, R; Shi, YX; Wang, RY; Battula, VL; Konoplev, S; Strunk, D; Hofmann, NA; Reinisch, A; Konopleva, M; Andreeff, M
BLOOD. 2012; 119(21): 4971-4980.
Originalarbeiten (Zeitschrift)
Oxygen sensing mesenchymal progenitors promote neo-vasculogenesis in a humanized mouse model in vivo.
Hofmann, NA; Ortner, A; Jacamo, RO; Reinisch, A; Schallmoser, K; Rohban, R; Etchart, N; Fruehwirth, M; Beham-Schmid, C; Andreeff, M; Strunk, D;
PLoS One. 2012; 7(9):e44468
Originalarbeiten (Zeitschrift)
Endothelial colony-forming progenitor cell isolation and expansion.
Hofmann, NA; Reinisch, A; Strunk, D;
Methods Mol Biol. 2012; 879: 381-387.
Originalarbeiten (Zeitschrift)
Transplantation and tracking of human-induced pluripotent stem cells in a pig model of myocardial infarction: assessment of cell survival, engraftment, and distribution by hybrid single photon emission computed tomography/computed tomography of sodium iodide symporter transgene expression.
Templin, C; Zweigerdt, R; Schwanke, K; Olmer, R; Ghadri, JR; Emmert, MY; Muller, E; Kuest, SM; Cohrs, S; Schibli, R; Kronen, P; Hilbe, M; Reinisch, A; Strunk, D; Haverich, A; Hoerstrup, S; Luscher, TF; Kaufmann, PA; Landmesser, U; Martin, U
CIRCULATION. 2012; 126(4): 430-439.
Originalarbeiten (Zeitschrift)
Human dermis harbors distinct mesenchymal stromal cell subsets.
Vaculik, C; Schuster, C; Bauer, W; Iram, N; Pfisterer, K; Kramer, G; Reinisch, A; Strunk, D; Elbe-Burger, A
J INVEST DERMATOL. 2012; 132(3 Pt 1): 563-574.
Originalarbeiten (Zeitschrift)
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
Platelet-derived factors preserve human mesenchymal cell stemness and promote endochondral bone and marrow niche formation via PDGF-receptor signalling
Etchart, N; Reinisch, A; Ortner, A; Fruhwirth, M; Hofmann, N; Rohban, R; Url, C; Schallmoser, K; Beham-Schmid, C; Strunk, D
BONE MARROW TRANSPL. 2012; 47: S49-S50.
Abstracts (Zeitschrift)
Collagen receptor-mediated mechanochemical signalling modulates human pro-angiogenic mesenchymal stem/progenitor cells during neovascularisation
Gimona, M; Rohban, R; Lener, T; Oller, M; Schallmoser, K; Strunk, D; Rohde, E
BONE MARROW TRANSPL. 2012; 47: S317-S317.
Abstracts (Zeitschrift)
Collagen Receptor-Mediated Mechanochemical Signaling Contributes to Human Pro-Angiogenic Mesenchymal Stem/Progenitor Cell-Induced Neo-Vasculogenesis
Gimona, M; Rohban, R; Lener, T; Peckl-Schmid, D; Oeller, M; Schallmoser, K; Strunk, D; Rohde, E
BLOOD. 2012; 120(21):
Abstracts (Zeitschrift)
Therapeutic neo-vasculogenesis in vivo is promoted by oxygen sensing mesenchymal stem/progenitor cells
Hofmann, NA; Ortner, A; Jacamo, RO; Reinisch, A; Etchart, N; Schallmoser, K; Fruehwirth, M; Rohban, R; Beham-Schmid, C; Andreeff, M; Strunk, D
BONE MARROW TRANSPL. 2012; 47: S319-S320.
Abstracts (Zeitschrift)
Organotypic Epigenetic Signature Predicts Bone and Marrow Niche Forming Capacity of Stromal Progenitors in a Novel Mouse Model in Vivo
Reinisch, A; Etchart, N; Hofmann, NA; Fruhwirth, M; Ortner, A; Thaler, D; Feilhauer, B; Hartwig, UF; Beham-Schmid, C; Trajanosky, S; Wagner, W; Alves, F; Schallmoser, K; Andreeff, M; Strunk, D
BLOOD. 2012; 120(21):
Abstracts (Zeitschrift)
Bone and haematopoietic niche formation is predetermined by a specific epigenetic signature
Reinisch, A; Etchart, N; Hofmann, NA; Fruhwirth, M; Thaler, D; Feilhauer, B; Ortner, A; Beham-Schmid, C; Trajanoski, S; Wagner, W; Schallmoser, K; Strunk, D
BONE MARROW TRANSPL. 2012; 47: S48-S49.
Abstracts (Zeitschrift)
Early in vivo signalling signature during human stem/progenitor cell-derived neo-vasculogenesis
Rohban, R; Etchart, N; Reinisch, A; Hofmann, N; Thaler, D; Feilhauer, B; Dacheva, M; Schallmoser, K; Rohde, E; Strunk, D
BONE MARROW TRANSPL. 2012; 47: S49-S49.
Abstracts (Zeitschrift)
Maintenance of Osteogenic Differentiation Capacity of MSPC Despite Amplified Proliferation Under Elevated Oxgen Conditions
Schallmoser, K; Hofmann, NA; Reinisch, A; Ortner, A; Url, C; Etchart, N; Joussen, S; Wagner, W; Strunk, D
BLOOD. 2012; 120(21):
Abstracts (Zeitschrift)
Elevated oxygen environment boosts MSPC proliferation without senescence aggravation
Schallmoser, K; Ortner, A; Hofmann, NA; Etchart, N; Joussen, S; Url, C; Wagner, W; Strunk, D
BONE MARROW TRANSPL. 2012; 47: S319-S319.
Abstracts (Zeitschrift)
Evaluating immunogenicity of human endothelial colony forming cells for application in cell-based therapies
Souidi, N; Schallmoser, K; Strunk, D; Schmidt-Lucke, C; Volk, HD; Seifert, M
J TISSUE ENG REGEN M. 2012; 6: 247-247.
Abstracts (Zeitschrift)
Xeno-free culturing of human muscle precursor cells (MPC) for clinical application
Zouraq, FA; Salemi, S; Largo, RA; Schallmoser, K; Strunk, D; Susler, T; Eberli, D
J TISSUE ENG REGEN M. 2012; 6: 132-132.
Abstracts (Zeitschrift)
Originalbeiträge in Sammelwerk (Buchbeitrag)
Animal Protein-free Expansion of Human Mesenchymal Stem/progenitor Cells.
Schallmoser, K; Etchart, N; Strunk, D; Rohde, E;
In: Allen, DS; Strunk, D (Ed.)
editors(s). Regenerative Therapy Using Blood-Derived Stem cells.. p. 53-70.
2011
Beiträge in Fachzeitschriften
Globular domain of adiponectin: promising target molecule for detection of atherosclerotic lesions.
Almer, G; Saba-Lepek, M; Haj-Yahya, S; Rohde, E; Strunk, D; Fröhlich, E; Prassl, R; Mangge, H;
Biologics. 2011; 5: 9-105.
Originalarbeiten (Zeitschrift)
Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing"s sarcoma.
Ban, J; Jug, G; Mestdagh, P; Schwentner, R; Kauer, M; Aryee, DNT; Schaefer, KL; Nakatani, F; Scotlandi, K; Reiter, M; Strunk, D; Speleman, F; Vandesompele, J; Kovar, H
ONCOGENE. 2011; 30(18): 2173-2180.
Originalarbeiten (Zeitschrift)
Immunomodulative efficacy of bone marrow-derived mesenchymal stem cells cultured in human platelet lysate.
Flemming, A; Schallmoser, K; Strunk, D; Stolk, M; Volk, HD; Seifert, M;
J Clin Immunol. 2011; 31(6): 1143-1156.
Originalarbeiten (Zeitschrift)
Pro-angiogenic induction of myeloid cells for therapeutic angiogenesis can induce mitogen-activated protein kinase p38-dependent foam cell formation.
Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Fröhlich, E; Rechberger, G; Lanzer, G; Kratky, D; Strunk, D;
CYTOTHERAPY. 2011; 13(4): 503-512.
Originalarbeiten (Zeitschrift)
Endothelial progenitor cells: quod erat demonstrandum?
Strunk, D
CURR PHARM DESIGN. 2011; 17(30): 324-351.
Übersichtsarbeiten
Thiolated polyacrylic acid-modified iron oxide nanoparticles for in vitro labeling and MRI of stem cells.
Vetter, A; Reinisch, A; Strunk, D; Kremser, C; Hahn, HW; Huck, CW; Ostermann, T; Leithner, K; Bernkop-Schnurch, A
J DRUG TARGET. 2011; 19(7): 56-72.
Originalarbeiten (Zeitschrift)
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
Human Extramedullary Bone and Bone Marrow in Mice: First In Vivo Model of a Genetically Controlled Hematopoietic Environment
Chen, Y; Jacamo, RO; Hofmann, NA; Shi, YX; Wang, RY; Konoplev, S; Strunk, D; Konopleva, M; Andreeff, M
BLOOD. 2011; 118(21): 584-584.
Abstracts (Zeitschrift)
Human platelet-derived factors maintain a bone and marrow niche-competent function of mesenchymal stem/progenitor cells
Etchart, N; Reinisch, A; Gungl, D; Hofmann, NA; Rohban, R; Ortner, A; Rankl, J; Hofmeister, A; Beham-Schmid, C; Schallmoser, K; Strunk, D
BONE MARROW TRANSPL. 2011; 46: S303-S303.
Abstracts (Zeitschrift)
Platelet-Derived Factors Allow Human Mesenchymal Stem Cells to Spontaneously Undergo Endochondral Bone Differentiation and Provide Bone Marrow Support in a Xenogenic In Vivo Model
Etchart, N; Reinisch, A; Ortner, A; Fruhwirth, M; Rohban, R; Url, C; Schallmoser, K; Beham-Schmid, C; Strunk, D
BLOOD. 2011; 118(21): 583-584.
Abstracts (Zeitschrift)
Neo-Vasculogenesis In Vivo Is Facilitated by Oxygen Sensing Mesenchymal Stem and Pogenitor Cells
Hofmann, NA; Ortner, A; Jacamo, RO; Reinisch, A; Schallmoser, K; Fruewirth, M; Diwoky, C; Rohban, R; Beham-Schmid, C; Andreeff, M; Strunk, D
BLOOD. 2011; 118(21): 319-319.
Abstracts (Zeitschrift)
Vascular regeneration in vivo is promoted by oxygen sensing mesenchymal stem and progenitor cells
Hofmann, NA; Reinisch, A; Ortner, A; Etchart, N; Schallmoser, K; Absenger, M; Strunk, D
BONE MARROW TRANSPL. 2011; 46: S302-S302.
Abstracts (Zeitschrift)
UCBT with low-dose ATG in adults
Linkesch, W; Neumeister, P; Zinke-Cerwenka, W; Strunk, D; Sill, H
BONE MARROW TRANSPL. 2011; 46: S128-S129.
Abstracts (Zeitschrift)
Results of UCBT with ATG in adults
Linkesch, W; Sill, H; Zinke-Cerwenka, W; Neumeister, P; Strunk, D
ONKOLOGIE. 2011; 34: 271-271.
Abstracts (Zeitschrift)
Human dermal-derived interfollicular mesenchymal stem cells drive the differentiation of naive helper T cells towards a regulatory phenotype without provision of costimulatory molecules
Pfisterer, K; Vaculik, C; Kramer, C; Strunk, D; Elbe-Burger, A
J INVEST DERMATOL. 2011; 131: S97-S97.
Abstracts (Zeitschrift)
Unexpected somatic restriction of mesenchymal stem and progenitor cells after transplantation in vivo
Reinisch, A; Etchart, N; Hofmann, NA; Gungl, D; Ortner, A; Rankl, J; Beham-Schmid, C; Schallmoser, K; Strunk, D
BONE MARROW TRANSPL. 2011; 46: S302-S303.
Abstracts (Zeitschrift)
Dissociation of In Vivo and in Vitro Differentiation Capacity of Human Mesenchymal Stem Cells Is Reflected by a Tissue Specific Epigenetic Memory
Reinsch, A; Liechtenstein, N; Hofmann, NA; Ortner, A; Fruhwirth, M; Schallmoser, K; Beham-Schmid, C; Strunk, D
BLOOD. 2011; 118(21): 1027-1028.
Abstracts (Zeitschrift)
Identification of early in vivo signalling signature during regenerative stem cell therapy using proteomic profiling
Rohban, R; Reinisch, A; Rohde, E; Hofmann, NA; Gimona, M; Etchart, N; Ortner, A; Strunk, D
BONE MARROW TRANSPL. 2011; 46: S50-S50.
Abstracts (Zeitschrift)
2010
Beiträge in Fachzeitschriften
A case of generalized MALT lymphoma with IgM paraproteinemia and peripheral blood involvement.
Reitter, S; Neumeister, P; Beham-Schmid, C; Emberger, W; Strunk, D; Brezinschek, R; Linkesch, W; Schmidt, HH
ANN HEMATOL. 2010; 89(2): 213-214.
Letter
Replicative senescence-associated gene expression changes in mesenchymal stromal cells are similar under different culture conditions.
Schallmoser, K; Bartmann, C; Rohde, E; Bork, S; Guelly, C; Obenauf, AC; Reinisch, A; Horn, P; Ho, AD; Strunk, D; Wagner, W;
HAEMATOL-HEMATOL J. 2010; 95(6): 86-74.
Originalarbeiten (Zeitschrift)
Prevention of oxidative stress in porcine islet isolation.
Stiegler, P; Stadlbauer, V; Hackl, F; Schaffellner, S; Iberer, F; Greilberger, J; Strunk, D; Zelzer, S; Lackner, C; Tscheliessnigg, K
J ARTIF ORGANS. 2010; 13(1): 38-47.
Originalarbeiten (Zeitschrift)
How to track cellular aging of mesenchymal stromal cells?
Wagner, W; Bork, S; Lepperdinger, G; Joussen, S; Ma, N; Strunk, D; Koch, C
AGING-US. 2010; 2(4): 224-230.
Originalarbeiten (Zeitschrift)
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
HYPOXIA MAINTAINS STEMNESS OF ENDOTHELIAL PROGENITOR CELLS
Hofmann, N; Reinisch, A; Schallmoser, K; Rohde, E; Absenger, M; Birner-Gruenberger, R; Strunk, D
HAEMATOL-HEMATOL J. 2010; 95: 97-97.
Abstracts (Zeitschrift)
Oxygen Sensing of Mesenchymal Stem and Progenitor Cells Facilitates Neo-Vasculogenesis In Vivo.
Hofmann, NA; Reinisch, A; Ortner, A; Schallmoser, K; Rohde, E; Absenger, M; Birner-Gruenberger, R; Strunk, D
BLOOD. 2010; 116(21): 1750-1750.
Abstracts (Zeitschrift)
Hypoxia maintains stemness of somatic endothelial colony forming progenitor cells
Hofmann, NA; Reinisch, A; Schallmoser, K; Rohde, E; Chatterjee, S; Absenger, M; Birner-Gruenberger, R; Strunk, D
BONE MARROW TRANSPL. 2010; 45: S279-S279.
Abstracts (Zeitschrift)
Long-term follow-up of minimal chronic graft-versus-host disease after reduced-intensity conditioning with pre-transplant low dose anti-thymocyte globulin in allogeneic stem cell transplantation
Langner, S; Staber, P; Linkesch, W; Strunk, D
BONE MARROW TRANSPL. 2010; 45: S145-S145.
Abstracts (Zeitschrift)
Human Vascular Progenitor Cells Can Guide Mesodermal Lineage Choice of Mesenchymal Stem and Progenitor Cells After Co-Transplantation In Vivo
Reinisch, A; Etchart, N; Hofmann, NA; Ortner, A; Rohde, E; Schallmoser, K; Beham-Schmid, C; Dullin, C; Diwoky, C; Hofmeister, A; Stollberger, R; Alves, F; Strunk, D
BLOOD. 2010; 116(21): 414-415.
Abstracts (Zeitschrift)
STABLE VESSEL GENERATION TROUGH APPLICATION OF BLOOD-DERIVED ENDOTHELIAL COLONY FORMING PROGENITOR CELLS (ECFCS) AND MESENCHYMAL STROMAL/STEM CELLS (MSCS)
Reinisch, A; Hofmann, N; Obenauf, A; Karl, K; Rohde, E; Schallmoser, K; Thaler, D; Fruhwirth, M; Flicker, K; Linkesch, W; Speicher, M; Strunk, D
HAEMATOL-HEMATOL J. 2010; 95: 208-208.
Abstracts (Zeitschrift)
VASCULAR PROGENITOR CELLS CAN INSTRUCT DEVELOPMENTAL FATE DECISION OF CD146(+) MESENCHYMAL STROMAL/STEM CELLS IN VIVO
Reinisch, A; Hofmann, N; Ortner, A; Etchart, N; Beham-Schmid, C; Dullin, C; Diwoky, C; Hofmeister, A; Stollberger, R; Alves, F; Strunk, D
HAEMATOL-HEMATOL J. 2010; 95: 479-479.
Abstracts (Zeitschrift)
Sustained vessel formation through co-transplantation of endothelial colony-forming progenitor cells with mesenchymal stromal cells
Reinisch, A; Hofmann, NA; Obenauf, A; Kashofer, K; Rohde, E; Schallmoser, K; Thaler, D; Fruhwirth, M; Flicker, K; Linkesch, W; Speicher, M; Strunk, D
BONE MARROW TRANSPL. 2010; 45: S52-S52.
Abstracts (Zeitschrift)
Vascular progenitor cells can instruct skeletal stem cells during developmental fate decisions
Reinisch, A; Hofmann, NA; Ortner, A; Etchart, N; Beham-Schmidt, C; Dullin, C; Diwoky, C; Hofmeister, A; Stollberger, R; Alves, F; Strunk, D
BONE MARROW TRANSPL. 2010; 45: S53-S53.
Abstracts (Zeitschrift)
BLOOD AND MARROW-DERIVED PROGENITORS ARE SUSCEPTIBLE TO MAPK P38-DEPENDENT FOAM CELL INDUCTION
Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, N; Pfeifer, T; Rechberger, G; Lanzer, G; Kratky, D; Strunk, D
HAEMATOL-HEMATOL J. 2010; 95: 436-436.
Abstracts (Zeitschrift)
THERAPEUTIC ANGIOGENESIS WITH CELLULAR THERAPY: PRO-ANGIOGENIC INDUCTION OF MYELOID CELLS CAN FAVOR MAPK P38-DEPENDENT FOAM CELL DEVELOPMENT
Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Lanzer, G; Strunk, D
VOX SANG. 2010; 99: 20-20.
Abstracts (Zeitschrift)
MAPK p38-dependent foam cell formation of myeloid cells after pro-angiogenic induction as a risk factor of therapeutic angiogenesis
Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Rechberger, G; Lanzer, G; Linkesch, W; Kratky, D; Strunk, D
BONE MARROW TRANSPL. 2010; 45: S283-S283.
Abstracts (Zeitschrift)
SENESCENCE-ASSOCIATED GENE EXPRESSION CHANGES IN MESENCHYMAL STROMAL/STEM CELLS
Schallmoser, K; Bartmann, C; Rohde, E; Bork, S; Guelly, C; Obenauf, A; Reinisch, A; Horn, P; Ho, A; Linkesch, W; Lanzer, G; Wagner, W; Strunk, D
HAEMATOL-HEMATOL J. 2010; 95: 98-98.
Abstracts (Zeitschrift)
Replicative senescence-associated gene expression changes in mesenchymal stromal cells
Schallmoser, K; Bartmann, C; Rohde, E; Bork, S; Guelly, C; Obenauf, AC; Reinisch, A; Hom, P; Ho, AD; Linkesch, W; Lanzer, G; Wagner, W; Strunk, D
BONE MARROW TRANSPL. 2010; 45: S281-S281.
Abstracts (Zeitschrift)
SIMILARITY OF REPLICATIVE SENESCENCE-ASSOCIATED GENE EXPRESSION CHANGES IN MESENCHYMAL STROMAL CELLS UNDER VARIOUS CULTURE CONDITIONS
Schallmoser, K; Bartmann, C; Rohde, E; Bork, S; Guelly, C; Obenauf, AC; Reinisch, A; Horn, P; Ho, AD; Linkesch, W; Lanzer, G; Wagner, W; Strunk, D
VOX SANG. 2010; 99: 481-482.
Abstracts (Zeitschrift)
Genomic Stability of Mesenchymal Stromal/Stem Cells After Long-Term Culture
Schallmoser, K; Rohde, E; Obenauf, AC; Reinisch, A; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D
TRANSFUSION. 2010; 50: 24A-24A.
Abstracts (Zeitschrift)
GENOMIC STABILITY IN LONG-TERM CULTURED MESENCHYMAL STROMAL/STEM CELLS
Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, A; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D
HAEMATOL-HEMATOL J. 2010; 95: 97-97.
Abstracts (Zeitschrift)
Alteration of genomic stability in long-term cultured mesenchymal stromal cells
Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, AC; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D
BONE MARROW TRANSPL. 2010; 45: S280-S280.
Abstracts (Zeitschrift)
ENDOTHELIAL COLONY-FORMING CELL OUTGROWTH IS CORRELATED WITH INTIMA MEDIA THICKNESS AND CARDIOVASCULAR RISK FACTORS IN TYPE 2 DIABETIC PATIENTS
Sourij, H; Hofmann, NA; Tripolt, N; Reinisch, A; Eder, M; Pieber, TR; Strunk, D
ATHEROSCLEROSIS SUPP. 2010; 11(2): 141-141.
Abstracts (Zeitschrift)
Combined action of endothelial and mesenchymal niche cells to amplify haematopoietic progenitor expansion in a humanized system
Thaler, D; Fruthwirth, M; Reinisch, A; Schallmoser, K; Rohde, E; Hofmann, NA; Linkesch, W; Hartwig, U; Strunk, D
BONE MARROW TRANSPL. 2010; 45: S53-S53.
Abstracts (Zeitschrift)
2009
Beiträge in Fachzeitschriften
Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow.
Bieback, K; Hecker, A; Kocaömer, A; Lannert, H; Schallmoser, K; Strunk, D; Klüter, H;
Stem Cells. 2009; 27(9): 233-241.
Originalarbeiten (Zeitschrift)
Isolation and large scale expansion of adult human endothelial colony forming progenitor cells.
Hofmann, NA; Reinisch, A; Strunk, D;
J Vis Exp. 2009;
Originalarbeiten (Zeitschrift)
IFPA meeting 2008 workshops report.
Lash, GE; Ansari, T; Bischof, P; Burton, GJ; Chamley, L; Crocker, I; Dantzer, V; Desoye, G; Drewlo, S; Fazleabas, A; Jansson, T; Keating, S; Kliman, HJ; Lang, I; Mayhew, T; Meiri, H; Miller, RK; Nelson, DM; Pfarrer, C; Roberts, C; Sammar, M; Sharma, S; Shiverick, K; Strunk, D; Turner, MA; Huppertz, B
PLACENTA. 2009; 30 Suppl A: S-14.
Übersichtsarbeiten
Humanized large-scale expanded endothelial colony-forming cells function in vitro and in vivo.
Reinisch, A; Hofmann, NA; Obenauf, AC; Kashofer, K; Rohde, E; Schallmoser, K; Flicker, K; Lanzer, G; Linkesch, W; Speicher, MR; Strunk, D;
Blood. 2009; 113(26): 6716-6725.
Originalarbeiten (Zeitschrift)
Isolation and animal serum free expansion of human umbilical cord derived mesenchymal stromal cells (MSCs) and endothelial colony forming progenitor cells (ECFCs).
Reinisch, A; Strunk, D;
J Vis Exp. 2009; (32):
Originalarbeiten (Zeitschrift)
Basic research and clinical applications of non-hematopoietic stem cells, 4-5 April 2008, Tubingen, Germany.
Schafer, R; Dominici, M; Muller, I; Horwitz, E; Asahara, T; Bulte, JWM; Bieback, K; Le Blanc, K; Buhring, HJ; Capogrossi, MC; Dazzi, F; Gorodetsky, R; Henschler, R; Handgretinger, R; Kajstura, J; Kluger, PJ; Lange, C; von Luettichau, I; Mertsching, H; Schrezenmeier, H; Sievert, KD; Strunk, D; Verfaillie, C; Northoff, H
CYTOTHERAPY. 2009; 11(2): 245-255.
Übersichtsarbeiten
The particle gel immunoassay as a rapid test to rule out heparin-induced thrombocytopenia?
Schallmoser, K; Drexler, C; Rohde, E; Strunk, D; Groselj-Strele, A; Lanzer, G; Kroll, H; Panzer, S;
J Thorac Cardiovasc Surg. 2009; 137(3): 781-783.
Editorials
Platelet-derived growth factors for GMP-compliant propagation of mesenchymal stromal cells.
Schallmoser, K; Rohde, E; Bartmann, C; Obenauf, AC; Reinisch, A; Strunk, D;
Biomed Mater Eng. 2009; 19(4-5): 271-276.
Originalarbeiten (Zeitschrift)
Preparation of pooled human platelet lysate (pHPL) as an efficient supplement for animal serum-free human stem cell cultures.
Schallmoser, K; Strunk, D;
J Vis Exp. 2009; (32):
Originalarbeiten (Zeitschrift)
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
Impact of mesenchymal stem cell transfusion on thrombotic microangiopathy post haematopoietic stem cell transplantation
Ansari, M; Kindler, V; Delco, C; Salah, V; Chalandon, Y; Gumy-Pause, F; Rougemont, A; Moll, S; Parvex, P; Chehade, H; Strunk, D; Passweg, J; Ozsahin, H
BONE MARROW TRANSPL. 2009; 43: S193-S193.
Abstracts (Zeitschrift)
Contribution of endothelial and mesenchymal niche cells to haematopoietic progenitor expansion in a humanised system
Fruehwirth, M; Thaler, D; Reinisch, A; Schallmoser, K; Rohde, E; Hofmann, NA; Linkesch, W; Strunk, D
BONE MARROW TRANSPL. 2009; 43: S188-S189.
Abstracts (Zeitschrift)
Porcine islet cell isolation for xenotransplantation: an optimized method with minimized oxidative stress for the PIC
Koestenbauer, S; Stiegler, P; Stadlbauer-Kollner, V; Schaffellner, S; Iberer, F; Greilberger, J; Strunk, D; Lackner, K; Hackl, F; Zelzer, S; Tscheliesnigg, K
HUM GENE THER. 2009; 20(11): 1480-1480.
Abstracts (Zeitschrift)
Vascular regeneration by adult blood-derived endothelial colony-forming cells expanded under animal serum-free conditions
Reinisch, A; Hofmann, NA; Obenauf, A; Kashofer, K; Rohde, E; Schallmoser, K; Thaler, D; Fruehwirth, M; Flicker, K; Linkesch, W; Speicher, M; Strunk, D
BONE MARROW TRANSPL. 2009; 43: S19-S20.
Abstracts (Zeitschrift)
Pro-atherogenic risk of cellular therapy for vascular regeneration?
Rohde, E; Pfeifer, T; Schallmoser, K; Reinisch, A; Hofmann, NA; Froehlich, E; Rechberger, G; Lanzer, G; Kratky, D; Strunk, D
BONE MARROW TRANSPL. 2009; 43: S203-S204.
Abstracts (Zeitschrift)
Evidence for genomic stability of bone marrow-derived MSCS after large-scale expansion in a humanised system
Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, A; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D
BONE MARROW TRANSPL. 2009; 43: S187-S187.
Abstracts (Zeitschrift)
2008
Beiträge in Fachzeitschriften
Clinical Protocols for the Isolation and Expansion of Mesenchymal Stromal Cells.
Bieback, K; Schallmoser, K; Klutera, H; Strunk, D
TRANSFUS MED HEMOTH. 2008; 35(4): 286-294.
Originalarbeiten (Zeitschrift)
Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum.
Schallmoser, K; Rohde, E; Reinisch, A; Bartmann, C; Thaler, D; Drexler, C; Obenauf, AC; Lanzer, G; Linkesch, W; Strunk, D;
Tissue Eng Part C Methods. 2008; 14(3):185-196
Originalarbeiten (Zeitschrift)
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
Combined Action of Endothelial and Mesenchymal Niche Cells to Amplify Hematopoietic Progenitor Expansion in a Humanized System
Frohwirth, M; Thaler, D; Reinisch, A; Schallmoser, K; Rohde, E; Hofmann, NA; Linkesch, W; Strunk, D
BLOOD. 2008; 112(11): 840-840.
Abstracts (Zeitschrift)
Human platelet-derived factors regulate gene expression profile and function of human multipotent mesenchymal stromal cells
Reinisch, A; Bartmann, C; Schallmoser, K; Rohde, E; Lanzer, G; Linkesch, W; Strunk, D
BONE MARROW TRANSPL. 2008; 41: S128-S129.
Abstracts (Zeitschrift)
Molecular imaging of bone marrow stromal cells
Reinisch, A; Diwoky, C; Hofmann, N; Schallmoser, K; Linkesch, W; Stollberger, R; Strunk, D
BONE MARROW TRANSPL. 2008; 41: S432-S432.
Abstracts (Zeitschrift)
Making Functional Endothelial Progenitors: Humanized Large-Scale Animal Serum-Free Propagated Adult Blood-Derived Endothelial Colony-Forming Cells Assemble Stable Perfused Vessels in Vivo
Reinisch, A; Hofmann, NA; Obenauf, HC; Kashofer, K; Rohde, E; Thaler, D; Friihwirth, M; Linkesch, W; Speicher, MR; Strunk, D
BLOOD. 2008; 112(11): 659-659.
Abstracts (Zeitschrift)
Combating Cardiovascular Disease: Is There a Risk of Foam Cell Formation in Trahsplanted Angiocompetent Cells Compromising Intended Beneficial Effects of Vascular Regenerative Therapy?.
Rohde, E; Aflaki, E; Froehlich, E; Lanzer, G; Kratky, D; Strunk, D
BLOOD. 2008; 112(11): 665-666.
Abstracts (Zeitschrift)
Excluding HIT Diagnosis by a Particle Gel Immunoassay
Schallmoser, K; Drexler, C; Rohde, E; Strunk, D; Groselj-Strele, A; Lanzer, G; Kroll, H; Panzer, S
BLOOD. 2008; 112(11): 1168-1168.
Abstracts (Zeitschrift)
Minimum requirements for fully humanised clinical scale propagation of multipotent mesenchymal stromal cells
Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, A; Speicher, M; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D
BONE MARROW TRANSPL. 2008; 41: S314-S314.
Abstracts (Zeitschrift)
Genomic Stability and Safety of MSCs after Animal Serum-Free Humanized Clinical Scale Propagation
Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, AC; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D
BLOOD. 2008; 112(11): 805-805.
Abstracts (Zeitschrift)
Originalbeiträge in Sammelwerk (Buchbeitrag)
GMP-Compliant Propagation of Human Multipotent Mesenchymal Stromal Cells
Rohde, E; Schallmoser, K; Bartmann, C; Reinisch, A;Strunk D
In: Gad, SC
editors(s). Pharmaceutical Manufacturing Handbook: Regulations and Quality
. John Wiley & Sons, Inc.
; p. 97-115.
2007
Beiträge in Fachzeitschriften
Two steps to functional mesenchymal stromal cells for clinical application.
Bartmann, C; Rohde, E; Schallmoser, K; Pürstner, P; Lanzer, G; Linkesch, W; Strunk, D;
Transfusion. 2007; 47(8): 1426-1435.
Originalarbeiten (Zeitschrift)
Humanized system to propagate cord blood-derived multipotent mesenchymal stromal cells for clinical application.
Reinisch, A; Bartmann, C; Rohde, E; Schallmoser, K; Bjelic-Radisic, V; Lanzer, G; Linkesch, W; Strunk, D;
Regen Med. 2007; 2(4):371-382
Originalarbeiten (Zeitschrift)
Immune cells mimic the morphology of endothelial progenitor colonies in vitro.
Rohde, E; Bartmann, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk, D;
Stem Cells. 2007; 25(7):1746-1752
Originalarbeiten (Zeitschrift)
Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells.
Schallmoser, K; Bartmann, C; Rohde, E; Reinisch, A; Kashofer, K; Stadelmeyer, E; Drexler, C; Lanzer, G; Linkesch, W; Strunk, D;
Transfusion. 2007; 47(8):143-146
Originalarbeiten (Zeitschrift)
Association of circulating endothelial progenitor cell growth in patients with Type 2 diabetes with type of glucose-lowering treatment.
Sourij, H; Strunk, D; Rohde, E; Wascher, TC
Diabet Med. 2007; 24(8):926-927
Letter
Roscovitine in B-chronic lymphocytic leukemia cells: high apoptosis-inducing efficacy and synergism with alemtuzumab independent of the patients" pretreatment status.
Weingrill, E; Wolfler, A; Strunk, D; Linkesch, W; Sill, H; Liebmann, PM
HAEMATOL-HEMATOL J. 2007; 92(9): 1286-1288.
Letter
Diagnostic value of Vbeta2-positive T-cell expansion in toxic shock syndrome.
Wenisch, C; Strunk, D; Krause, R; Smolle, KH
INT J DERMATOL. 2007; 46(6): 57-82.
Fallberichte
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
Human platelet-derived factors induce differential gene expression in bone marrow mesenchymal stem cells
Bartmann, C; Schallmoser, K; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D
HAEMATOL-HEMATOL J. 2007; 92: 318-318.
Abstracts (Zeitschrift)
Decreased chronic GVHD rate after reduced intensity conditioning with low dose ATG in allogeneic hematopoietic SCT
Langner, S; Staber, P; Strunk, D; Linkesch, W
HAEMATOL-HEMATOL J. 2007; 92: 220-220.
Abstracts (Zeitschrift)
Gene expression profiling of human multipotent mesenchymal stromal cells
Malischnik, C; Schallmoser, K; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D
BONE MARROW TRANSPL. 2007; 39: S51-S51.
Abstracts (Zeitschrift)
Clinical scale propagation of functional cord blood stem cells in a humanized system
Reinisch, A; Bartmann, C; Rohde, E; Schallmoser, K; Bielic-Radisic, V; Lanzer, G; Linkesch, W; Strunk, D
HAEMATOL-HEMATOL J. 2007; 92: 318-318.
Abstracts (Zeitschrift)
Clinical scale expansion of human cord blood-derived multipotent stem cells in a new FBS-free system
Reinisch, A; Malischnik, C; Rohde, E; Schallmoser, K; Bjelic-Radisic, V; Lanzer, G; Linkesch, W; Strunk, D
BONE MARROW TRANSPL. 2007; 39: S132-S133.
Abstracts (Zeitschrift)
Immune cells mimic endothelial progenitor colonies
Rohde, E; Bartmann, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk, D
TRANSFUSION. 2007; 47(3): 69A-69A.
Abstracts (Zeitschrift)
Immune cells mimic the morphology of endothelial progenitor colonies in vitro
Rohde, E; Bartmann, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk, D
HAEMATOL-HEMATOL J. 2007; 92: 315-315.
Abstracts (Zeitschrift)
Immune cells mimic endothelial progenitor colonies
Rohde, E; Malischnik, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk, D
BONE MARROW TRANSPL. 2007; 39: S123-S123.
Abstracts (Zeitschrift)
Radioimmunotherapy as a promising therapeutic option in patients with relapsed or refractory CD20(+) non-Hodgkins lymphoma
Rohn, A; Leitner, C; Brezinschek, RI; Sormann, S; Linkesch, W; Strunk, D
HAEMATOL-HEMATOL J. 2007; 92: 278-278.
Abstracts (Zeitschrift)
A novel system for highly efficient clinical scale propagation of human mesenchymal stem cells with human platelet lysate
Schallmoser, K; Bartmarm, C; Rohde, E; Reinisch, A; Kashofer, K; Emberger, W; Lanzer, G; Linkesch, W; Strunk, D
HAEMATOL-HEMATOL J. 2007; 92: 317-318.
Abstracts (Zeitschrift)
Two steps to clinical multipotent mesenchymal stromal cells with human platelet lysate
Schallmoser, K; Malischnik, C; Rohde, E; Reinisch, A; Kashofer, K; Lanzer, G; Linkesch, W; Strunk, D
BONE MARROW TRANSPL. 2007; 39: S110-S110.
Abstracts (Zeitschrift)
Animal serum-free clinical scale propagation of human MSC
Schallmoser, K; Reinisch, A; Bartmann, C; Rohde, E; Kashofer, K; Emberger, W; Lanzer, G; Linkesch, W; Strunk, D
TRANSFUSION. 2007; 47(3): 28A-28A.
Abstracts (Zeitschrift)
2006
Beiträge in Fachzeitschriften
CD45-positive cells of haematopoietic origin enhance chondrogenic marker gene expression in rat marrow stromal cells.
Ahmed, N; Vogel, B; Rohde, E; Strunk, D; Grifka, J; Schulz, MB; Grassel, S
Int J Mol Med. 2006; 18(2):233-240
Originalarbeiten (Zeitschrift)
Blood monocytes mimic endothelial progenitor cells.
Rohde, E; Malischnik, C; Thaler, D; Maierhofer, T; Linkesch, W; Lanzer, G; Guelly, C; Strunk, D
Stem Cells. 2006; 24(2):357-367
Originalarbeiten (Zeitschrift)
Stem cell therapy for ischemic heart disease: beginning or end of the road?
Stamm, C; Liebold, A; Steinhoff, G; Strunk, D
CELL TRANSPLANT. 2006; 15 Suppl 1: S47-S56.
Übersichtsarbeiten
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
Preclinical protocol: two steps to propagate human MSC for therapeutic application
Malischnik, C; Rohde, E; Thaler, D; Linkesch, W; Lanzer, G; Strunk, D
BONE MARROW TRANSPL. 2006; 37: S152-S152.
Abstracts (Zeitschrift)
Human platelet-derived factors regulate mesenchymal stem cell gene expression.
Malischnik, C; Schallmoser, K; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D
BLOOD. 2006; 108(11): 142B-142B.
Abstracts (Zeitschrift)
Immune cells mimic endothelial progenitor colonies.
Rohde, E; Malischnik, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk, D
BLOOD. 2006; 108(11): 513A-513A.
Abstracts (Zeitschrift)
Molecular mimicry: monocytes display endothelial cell related marker molecules
Rohde, E; Malischnik, C; Thaler, D; Maierhofer, T; Linkesch, W; Lanzer, G; Guelly, C; Strunk, D
BONE MARROW TRANSPL. 2006; 37: S24-S24.
Abstracts (Zeitschrift)
Human mesenchymal stem cell therapy: Platelet lysate supports efficient preclinical expansion.
Schallmoser, K; Malischnik, C; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D
BLOOD. 2006; 108(11): 1042A-1042A.
Abstracts (Zeitschrift)
2005
Beiträge in Fachzeitschriften
Phenotypic characterization and preclinical production of human lineage-negative cells for regenerative stem cell therapy.
Strunk, D; Rohde, E; Lanzer, G; Linkesch, W
Transfusion. 2005; 45(3):315-326
Originalarbeiten (Zeitschrift)
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
Low plating density boosts mesenchymal stem cell proliferation
Malischnika, C; Rohde, E; Thaler, D; Vogel, B; Linkesch, W; Lanzer, G; Schaider, H; Strunk, D
BONE MARROW TRANSPL. 2005; 35: S139-S140.
Abstracts (Zeitschrift)
Human lineage-negative cells for regenerative stem cell therapy
Rohde, E; Brulport, M; Malischnik, C; Thaler, D; Lanzer, G; Linkesch, W; Hengstler, J; Strunk, D
BONE MARROW TRANSPL. 2005; 35: S99-S100.
Abstracts (Zeitschrift)
How to define endothelial progenitor cells in human blood?
Rohde, E; Malischnik, C; Linkesch, W; Lanzer, G; Strunk, D
BONE MARROW TRANSPL. 2005; 35: S78-S78.
Abstracts (Zeitschrift)
Environmental conditioning of CFU-EC by primed blood monocytes
Thaler, D; Rohde, E; Malischnik, C; Linkesch, W; Lanzer, G; Strunk, D
BONE MARROW TRANSPL. 2005; 35: S115-S115.
Abstracts (Zeitschrift)
2004
Beiträge in Fachzeitschriften
Sunburn cell formation, dendritic cell migration, and immunomodulatory factor production after solar-simulated irradiation of sunscreen-treated human skin explants in vitro.
Hofmann-Wellenhof, R; Smolle, J; Roschger, A; Strunk, D; Hubmer, M; Hoffmann, C; Quehenberger, F; Horn, M; Kerl, H; Wolf, P
J INVEST DERMATOL. 2004; 123(4): 781-787.
Originalarbeiten (Zeitschrift)
Neutrophilic leukemoid reaction as the presenting feature of de novo and therapy-related acute leukemias.
Olipitz, W; Strunk, D; Beham-Schmid, C; Sill, H
ACTA HAEMATOL-BASEL. 2004; 111(4): 233-234.
Fallberichte
RT-PCR and FISH analysis of acute myeloid leukemia with t(8;16)(p11;p13) and chimeric MOZ and CBP transcripts: breakpoint cluster region and clinical implications.
Schmidt, HH; Strehl, S; Thaler, D; Strunk, D; Sill, H; Linkesch, W; Jager, U; Sperr, W; Greinix, HT; Konig, M; Emberger, W; Haas, O
LEUKEMIA. 2004; 18(6): 1115-1121.
Originalarbeiten (Zeitschrift)
Dendritic cell deficiency in early B cell chronic lymphocytic leukemia.
Strunk, D; Grube, R; Stodelmeyer, E; Linkesch, W
HAEMATOLOGICA. 2004; 89(1): 111-112.
Letter
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
Human lineage-negative cells for regenerative stem cell therapy
Rohde, E; Thaler, D; Lanzer, G; Linkesch, W; Strunk, D
BONE MARROW TRANSPL. 2004; 33: S171-S172.
Abstracts (Zeitschrift)
2003
Beiträge in Fachzeitschriften
inv(3)(q21q26) in AML/MDS: Monitoring of the malignant clone with interphase FISH.
Schmidt, HH; Pirc-Danoewinata, H; Linkesch, W; Strunk, D; Wieser, R;
Haematologica. 2003; 88(12): ECR38
Fallberichte
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
Characterization of human lineage-negative cells for regenerative stem cell therapy
Rohde, E; Lanzer, G; Linkesch, W; Strunk, D
BONE MARROW TRANSPL. 2003; 31: S203-S203.
Abstracts (Zeitschrift)
Prevalence of CD7(+) cells in CD34(-)/Lin(-) human hematopoietic stem cell fractions
Rohde, E; Lanzer, G; Linkesch, W; Strunk, D
TRANSFUSION. 2003; 43(9): 52A-53A.
Abstracts (Zeitschrift)
Immunophenotypic analysis and preclinical GMP-grade production of human lineage-negative cells for regenerative stem cell therapy.
Rohde, E; Lanzer, G; Linkesch, W; Strunk, D
BLOOD. 2003; 102(11): 463A-463A.
Abstracts (Zeitschrift)
2002
Beiträge in Fachzeitschriften
Restoration of erythropoiesis by rituximab in an adult patient with primary acquired pure red cell aplasia refractory to conventional treatment.
Auner, HW; Wolfler, A; Beham-Schmid, C; Strunk, D; Linkesch, W; Sill, H
BRIT J HAEMATOL. 2002; 116(3): 727-728.
Fallberichte
Impaired dendritic cell function in B-CLL
Strunk, D; Grube, R; Stadelmeyer, E; Chraust, S; Linkesch, W
. 2002; 205-209.
Originalarbeiten (Zeitschrift)
2001
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
UV-induced TNF alpha production is influenced by the application of sunscreens
Hofmann-Wellenhof, R; Smolle, J; Roschger, A; Strunk, D; Hubmer, M; Hoffmann, C; Horn, M; Kerl, H; Wolf, P
J INVEST DERMATOL. 2001; 117(3): 814-814.
Abstracts (Zeitschrift)
Alteration of dendritic cell function in B-CLL.
Stadelmeyer, E; Grube, R; Chraust, S; Linkesch, W; Strunk, D
BLOOD. 2001; 98(11): 287B-287B.
Abstracts (Zeitschrift)
2000
Beiträge in Fachzeitschriften
Adoptive transfer of vitiligo after allogeneic bone marrow transplantation for non-Hodgkin"s lymphoma.
Neumeister, P; Strunk, D; Apfelbeck, U; Sill, H; Linkesch, W
LANCET. 2000; 355(9212): 1334-1335.
Letter
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
UV-irradiation of human skin explants reduced migration of dendritic cells
Hofmann-Wellenhof, R; Strunk, D; Wolf, P; Hubmer, M; Legat, F; Smolle, J; Kerl, H
J INVEST DERMATOL. 2000; 114(1): 227-227.
Abstracts (Zeitschrift)
1999
Beiträge in Fachzeitschriften
Separation of sperm and vaginal cells based on ploidy, MHC class I-, CD45-, and cytokeratin expression for enhancement of DNA typing after sexual assault.
Schoell, WMJ; Klintschar, M; Mirhashemi, R; Strunk, D; Giuliani, A; Bogensberger, G; Pertl, B
Cytometry. 1999; 36(4):319-323
Originalarbeiten (Zeitschrift)
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
Peripheral blood dendritic cell deficiency in chronic lymphocytic leukemia (CLL) patients.
Grube, R; Chraust, S; Linkesch, W; Strunk, D
BLOOD. 1999; 94(10): 121A-121A.
Abstracts (Zeitschrift)
Human monocytes do not differentiate into Langerhans cells.
Schloegl, D; Chraust, S; Linkesch, W; Strunk, D
BLOOD. 1999; 94(10): 267B-267B.
Abstracts (Zeitschrift)
1998
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
Capillary leak syndrome with late onset after autografting for multiple myeloma.
Schmidt, HH; Sill, H; Jager, G; Neumeister, P; Strunk, D; Linkesch, W
BONE MARROW TRANSPL. 1998; 21: S91-S91.
Abstracts (Zeitschrift)
1997
Beiträge in Fachzeitschriften
A skin homing molecule defines the langerhans cell progenitor in human peripheral blood.
Strunk, D; Egger, C; Leitner, G; Hanau, D; Stingl, G
J Exp Med. 1997; 185(6):1131-1136
Originalarbeiten (Zeitschrift)
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
Acute myelogenous leukemia cells can be differentiated into dendritic cells in vitro.
Strunk, D; Linkesch, W
BLOOD. 1997; 90(10): 829-829.
Abstracts (Zeitschrift)
1996
Beiträge in Fachzeitschriften
Generation of human dendritic cells/Langerhans cells from circulating CD34+ hematopoietic progenitor cells.
Strunk, D; Rappersberger, K; Egger, C; Strobl, H; Kromer, E; Elbe, A; Maurer, D; Stingl, G
Blood. 1996; 87(4):1292-1302
Originalarbeiten (Zeitschrift)
Single human T cells stimulated in the absence of feeder cells transcribe interleukin-2 and undergo long-term clonal growth in response to defined monoclonal antibodies and cytokine stimulation.
SunderPlassmann, R; Breiteneder, H; Zimmermann, K; Strunk, D; Majdic, O; Knapp, W; Holter, W
Blood. 1996; 87(12):5179-5184
Originalarbeiten (Zeitschrift)
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
IL-4 enhances the yield and the immunostimulatory potency of murine bone marrow-derived dendritic cells.
Schneeberger, A; Koszik, F; Lenz, P; Kolesaric, A; Scheinecker, C; Strunk, D; Grauer, O; Kampgen, E; Elbe, A; Stingl, G
J INVEST DERMATOL. 1996; 107(3): 232-232.
Abstracts (Zeitschrift)
A skin homing receptor defines the progenitor of skin Langerhans cells in peripheral blood.
Strunk, D; Egger, C; Stingl, G
BLOOD. 1996; 88(10): 746-746.
Abstracts (Zeitschrift)
1995
Beiträge in Fachzeitschriften
Human melanocytes and melanoma cells constitutively express the Bcl-2 proto-oncogene in situ and in cell culture.
PLETTENBERG, A; BALLAUN, C; PAMMER, J; MILDNER, M; STRUNK, D; WENINGER, W; TSCHACHLER, E
Am J Pathol. 1995; 146(3):651-659
Originalarbeiten (Zeitschrift)
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
A SKIN HOMING MOLECULE DEFINES THE PROGENITOR OF DENDRITIC LANGERHANS CELLS
STRUNK, D; EGGER, C; STINGL, G
J INVEST DERMATOL. 1995; 105(3): 461-461.
Abstracts (Zeitschrift)
1994
Beiträge in Fachzeitschriften
Fetal skin-derived MHC class I+, MHC class II- dendritic cells stimulate MHC class I-restricted responses of unprimed CD8+ T cells.
ELBE, A; SCHLEISCHITZ, S; STRUNK, D; STINGL, G
J Immunol. 1994; 153(7):2878-2889
Originalarbeiten (Zeitschrift)
Expression of monoclonal antibody HECA-452-defined E-selectin ligands on Langerhans cells in normal and diseased skin.
KOSZIK, F; STRUNK, D; SIMONITSCH, I; PICKER, LJ; STINGL, G; PAYER, E
J Invest Dermatol. 1994; 102(5):773-780
Originalarbeiten (Zeitschrift)
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
FUNCTIONAL EXPRESSION OF THE COSTIMULATORY MOLECULE-B7 ON ACCESSORY CELLS FOR MHC CLASS I-RESTRICTED IMMUNE-RESPONSES
ELBE, A; REISER, H; STRUNK, D; STINGL, G
J CELL BIOCHEM. 1994; 308-308.
Abstracts (Zeitschrift)
HUMAN MELANOCYTES AND MELANOMA-CELLS EXPRESS THE BCL-2 PROTOONCOGENE IN-SITU AND IN CELL-CULTURE
PLETTENBERG, A; BALLAUN, C; PAMMER, J; MILDNER, M; STRUNK, D; WENINGER, W; TSCHACHLER, E
J INVEST DERMATOL. 1994; 103(3): 436-436.
Abstracts (Zeitschrift)
EXPRESSION OF THE BCL-2 PROTOONCOGENE IN NORMAL HUMAN EPIDERMIS
PLETTENBERG, A; BALLAUN, C; STRUNK, D; WENINGER, W; TSCHACHLER, E
J INVEST DERMATOL. 1994; 102(4): 645-645.
Abstracts (Zeitschrift)
LANGERHANS CELLS CAN BE GENERATED FROM CIRCULATING CD34+ PROGENITORS
STRUNK, D; ELBE, A; RAPPERSBERGER, K; STINGL, G
J INVEST DERMATOL. 1994; 103(3): 408-408.
Abstracts (Zeitschrift)
GENERATION OF LANGERHANS CELLS FROM PERIPHERAL-BLOOD STEM-CELLS
STRUNK, D; NEMETH, P; ELBE, A; RAPPERSBERGER, K; STINGL, G
FASEB J. 1994; 8(5): A989-A989.
Abstracts (Zeitschrift)
GENERATION OF LANGERHANS CELLS FROM CD34+ PERIPHERAL-BLOOD STEM-CELLS
STRUNK, D; NEMETH, P; ELBE, A; RAPPERSBERGER, K; STINGL, G
J INVEST DERMATOL. 1994; 102(4): 525-525.
Abstracts (Zeitschrift)
1993
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
THE CUTANEOUS LYMPHOCYTE-ASSOCIATED ANTIGEN IS EXPRESSED ON LANGERHANS CELLS IN NORMAL AND DISEASED SKIN
KOSZIK, F; STRUNK, D; STINGL, G; PAYER, E
J INVEST DERMATOL. 1993; 100(4): 442-442.
Abstracts (Zeitschrift)
A SUBPOPULATION OF LANGERHANS CELLS IN NORMAL AND DISEASED SKIN EXPRESS CUTANEOUS LYMPHOCYTE-ASSOCIATED ANTIGEN
PAYER, E; KOSZIK, F; STRUNK, D; STINGL, G
J INVEST DERMATOL. 1993; 100(4): 572-572.
Abstracts (Zeitschrift)
A SUBPOPULATION OF LANGERHANS CELLS IN NORMAL AND DISEASED SKIN EXPRESS CUTANEOUS LYMPHOCYTE-ASSOCIATED ANTIGEN
PAYER, E; KOSZIK, F; STRUNK, D; STINGL, G
CLIN RES. 1993; 41(2): A471-A471.
Abstracts (Zeitschrift)
MIGRATION KINETICS OF HUMAN EPIDERMAL LANGERHANS CELLS
STRUNK, D; ELBE, A; STINGL, G
J INVEST DERMATOL. 1993; 100(4): 574-574.
Abstracts (Zeitschrift)
MIGRATION KINETICS OF HUMAN EPIDERMAL LANGERHANS CELLS
STRUNK, D; ELBE, A; STINGL, G
CLIN RES. 1993; 41(2): A473-A473.
Abstracts (Zeitschrift)
1992
Beiträge in Fachzeitschriften
Inhibition of histamine release from human granulocytes by ions of the rare earth elements lanthanum and cerium.
GRUNER, S; SEHRT, I; MULLER, GM; ZWIRNER, A; STRUNK, D; SONNICHSEN, N
Agents Actions. 1992; 36(3-4):207-211
Originalarbeiten (Zeitschrift)
The influence of topical dermatological treatment modalities on epidermal Langerhans cells and contact sensitization in mice.
GRUNER, S; ZWIRNER, A; STRUNK, D; SONNICHSEN, N
Contact Dermatitis. 1992; 26(4):241-247
Originalarbeiten (Zeitschrift)
1991
Beiträge in Fachzeitschriften
Inhibition of Langerhans cell ATPase and contact sensitization by lanthanides--role of T-suppressor cells.
GRUNER, S; DIEZEL, W; STRUNK, D; ECKERT, R; SIEMS, W; ANHALT, GJ
J Invest Dermatol. 1991; 97(3):478-482
Originalarbeiten (Zeitschrift)
1990
Beiträge in Fachzeitschriften
Stimulation of the recruitment of epidermal Langerhans cells by splenopentin.
GRUNER, S; DIEZEL, W; STRUNK, D; ZWIRNER, A; SONNICHSEN, N; ANHALT, GJ
Arch Dermatol Res. 1990; 281(8):526-529
Originalarbeiten (Zeitschrift)
1989
Beiträge in Fachzeitschriften
[Contact hypersensitivity (DNCB test) and inhibition by the calcium channel blocker diltiazem].
Diezel, W; Gruner, S; Anhalt, GJ; Strunk, D; Shanks, M; Sönnichsen, N;
Dermatol Monatsschr. 1989; 175(3): 170-174.
Originalarbeiten (Zeitschrift)
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
SUPPRESSION OF CUTANEOUS CONTACT HYPERSENSITIVITY BY LANTHANUM
DIEZEL, W; GRUNER, S; STRUNK, D; ECKERT, R; SIEMS, W; DIAZ, LA; ANHALT, GJ
CLIN RES. 1989; 37(2): A349-A349.
Abstracts (Zeitschrift)
1987
Beiträge in Fachzeitschriften
[Effect of topical antipsoriatic agents on ATPase-positive epidermal Langerhans cells. Animal experiment studies].
Gruner, S; Strunk, D; Diezel, W;
Dermatol Monatsschr. 1987; 173(8):436-440
Originalarbeiten (Zeitschrift)